{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:38:40Z","timestamp":1790127520087,"version":"4.0.1"},"reference-count":358,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10072-025-08419-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:59:41Z","timestamp":1759730381000},"page":"6277-6319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MicroRNAs in neurodegenerative diseases: from molecular mechanisms to clinical biomarkers, detection methods and therapeutic strategies\u2014advances and challenges"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3702-2313","authenticated-orcid":false,"given":"Hafiz Muhammad Husnain","family":"Azam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehvish","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-6512","authenticated-orcid":false,"given":"Stefan","family":"R\u00f6diger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schierack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambreen","family":"Aisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"8419_CR1","doi-asserted-by":"publisher","first-page":"1386735","DOI":"10.3389\/fnmol.2024.1386735","volume":"17","author":"HMH Azam","year":"2024","unstructured":"Azam HMH, R\u00f6\u00dfling RI, Geithe C et al (2024) Microrna biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review. Front Mol Neurosci 17:1386735. https:\/\/doi.org\/10.3389\/fnmol.2024.1386735","journal-title":"Front Mol Neurosci"},{"key":"8419_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jamaneurol.2013.275","volume":"70","author":"PL De Jager","year":"2013","unstructured":"De Jager PL, Bennett DA (2013) An inflection point in gene discovery efforts for neurodegenerative diseases: from syndromic diagnoses toward endophenotypes and the epigenome. JAMA Neurol 70:719\u2013726. https:\/\/doi.org\/10.1001\/jamaneurol.2013.275","journal-title":"JAMA Neurol"},{"key":"8419_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1515\/revneuro-2019-0001","volume":"31","author":"J Chen","year":"2020","unstructured":"Chen J, Yang G, Yan Q et al (2020) Exosome-encapsulated MicroRNAs as promising biomarkers for alzheimer\u2019s disease. Rev Neurosci 31:77\u201387. https:\/\/doi.org\/10.1515\/revneuro-2019-0001","journal-title":"Rev Neurosci"},{"key":"8419_CR4","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/ijms19102937","volume":"19","author":"M Kritsilis","year":"2018","unstructured":"Kritsilis M, Rizou V, Koutsoudaki S PN, et al (2018) Ageing, cellular senescence and neurodegenerative disease. Int J Mol Sci 19:2937. https:\/\/doi.org\/10.3390\/ijms19102937","journal-title":"Int J Mol Sci"},{"issue":"4","key":"8419_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol 23(4):344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurol"},{"key":"8419_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"8419_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00496-7","volume":"16","author":"H Walgrave","year":"2021","unstructured":"Walgrave H, Zhou L, De Strooper B, Salta E (2021) The promise of microRNA-based therapies in alzheimer\u2019s disease: challenges and perspectives. Mol Neurodegener 16:76. https:\/\/doi.org\/10.1186\/s13024-021-00496-7","journal-title":"Mol Neurodegener"},{"key":"8419_CR8","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim M-O, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 10:a033118. https:\/\/doi.org\/10.1101\/cshperspect.a033118","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8419_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2217\/bmm-2016-0242","volume":"11","author":"V Viswambharan","year":"2017","unstructured":"Viswambharan V, Thanseem I, Vasu MM et al (2017) Mirnas as biomarkers of neurodegenerative disorders. Biomark Med 11:151\u2013167. https:\/\/doi.org\/10.2217\/bmm-2016-0242","journal-title":"Biomark Med"},{"key":"8419_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, Zuccato C, Belyaev ND et al (2008) A microRNA-based gene dysregulation pathway in huntington\u2019s disease. Neurobiol Dis 29:438\u2013445. https:\/\/doi.org\/10.1016\/j.nbd.2007.11.001","journal-title":"Neurobiol Dis"},{"key":"8419_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101803","volume":"190","author":"A Loffreda","year":"2020","unstructured":"Loffreda A, Nizzardo M, Arosio A et al (2020) MiR-129-5p: a key factor and therapeutic target in amyotrophic lateral sclerosis. Prog Neurobiol 190:101803. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101803","journal-title":"Prog Neurobiol"},{"key":"8419_CR12","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41593-022-01185-4","volume":"25","author":"YM Oh","year":"2022","unstructured":"Oh YM, Lee SW, Kim WK et al (2022) Age-related huntington\u2019s disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy. Nat Neurosci 25:1420\u20131433. https:\/\/doi.org\/10.1038\/s41593-022-01185-4","journal-title":"Nat Neurosci"},{"key":"8419_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nbt.2213","volume":"30","author":"C Caldas","year":"2012","unstructured":"Caldas C (2012) Cancer sequencing unravels clonal evolution. Nat Biotechnol 30:408\u2013410. https:\/\/doi.org\/10.1038\/nbt.2213","journal-title":"Nat Biotechnol"},{"key":"8419_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/sj.bjc.6605382","volume":"101","author":"MA Richards","year":"2009","unstructured":"Richards MA (2009) The national awareness and early diagnosis initiative in England: assembling the evidence. Br J Cancer 101:S1\u2013S4. https:\/\/doi.org\/10.1038\/sj.bjc.6605382","journal-title":"Br J Cancer"},{"key":"8419_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-27","volume":"4","author":"DE Bredesen","year":"2009","unstructured":"Bredesen DE (2009) Neurodegeneration in alzheimer\u2019s disease: caspases and synaptic element interdependence. Mol Neurodegener 4:27. https:\/\/doi.org\/10.1186\/1750-1326-4-27","journal-title":"Mol Neurodegener"},{"key":"8419_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrd3535","volume":"11","author":"EM Snyder","year":"2012","unstructured":"Snyder EM, Olin J, David FS (2012) Maximizing the value of diagnostics in Alzheimer\u2019s disease drug development. Nat Rev Drug Discov 11:183\u2013184. https:\/\/doi.org\/10.1038\/nrd3535","journal-title":"Nat Rev Drug Discov"},{"key":"8419_CR17","unstructured":"von Bernhardi R (2008) Neurodegenerative diseases: from molecular concepts to therapeutic targets.\u00a0Nova Publishers"},{"issue":"8","key":"8419_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neurobiolaging.2010.05.003","volume":"31","author":"LG Apostolova","year":"2010","unstructured":"Apostolova LG, Hwang KS, Andrawis JP et al (2010) 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging 31(8):1284\u20131303. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.05.003","journal-title":"Neurobiol Aging"},{"key":"8419_CR19","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","volume":"68","author":"AM Fagan","year":"2011","unstructured":"Fagan AM, Shaw LM, Xiong C et al (2011) Comparison of analytical platforms for cerebrospinal fluid measures of \u03b2-amyloid 1\u201342, total tau, and P-tau181 for identifying alzheimer disease amyloid plaque pathology. Arch Neurol 68:1137\u20131144. https:\/\/doi.org\/10.1001\/archneurol.2011.105","journal-title":"Arch Neurol"},{"key":"8419_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1479-8301.2012.00409.x","volume":"12","author":"T Mori","year":"2012","unstructured":"Mori T, Maeda J, Shimada H et al (2012) Molecular imaging of dementia. Psychogeriatrics 12:106\u2013114. https:\/\/doi.org\/10.1111\/j.1479-8301.2012.00409.x","journal-title":"Psychogeriatrics"},{"key":"8419_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023112","volume":"6","author":"E Nagele","year":"2011","unstructured":"Nagele E, Han M, DeMarshall C et al (2011) Diagnosis of alzheimer\u2019s disease based on disease-specific autoantibody profiles in human sera. PLoS One 6:e23112. https:\/\/doi.org\/10.1371\/journal.pone.0023112","journal-title":"PLoS One"},{"key":"8419_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C et al (2007) Classification and prediction of clinical alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat Med 13:1359\u20131362. https:\/\/doi.org\/10.1038\/nm1653","journal-title":"Nat Med"},{"key":"8419_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2010.11.054","volume":"144","author":"MM Reddy","year":"2011","unstructured":"Reddy MM, Wilson R, Wilson J et al (2011) Identification of candidate IgG biomarkers for alzheimer\u2019s disease via combinatorial library screening. Cell 144:132\u2013142. https:\/\/doi.org\/10.1016\/j.cell.2010.11.054","journal-title":"Cell"},{"key":"8419_CR24","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J et al (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317:1220\u20131224. https:\/\/doi.org\/10.1126\/science.1140481","journal-title":"Science"},{"key":"8419_CR25","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3892\/etm.2019.7855","volume":"18","author":"Q Yang","year":"2019","unstructured":"Yang Q, Zhao Q, Yin Y (2019) MiR\u2013133b is a potential diagnostic biomarker for alzheimer\u2019s disease and has a neuroprotective role. Exp Ther Med 18:2711\u20132718. https:\/\/doi.org\/10.3892\/etm.2019.7855","journal-title":"Exp Ther Med"},{"key":"8419_CR26","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.cclet.2018.10.038","volume":"29","author":"L Guo","year":"2018","unstructured":"Guo L, Chen H, He N, Deng Y (2018) Effects of surface modifications on the physicochemical properties of iron oxide nanoparticles and their performance as anticancer drug carriers. Chin Chem Lett 29:1829\u20131833. https:\/\/doi.org\/10.1016\/j.cclet.2018.10.038","journal-title":"Chin Chem Lett"},{"key":"8419_CR27","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1166\/jbn.2013.1665","volume":"9","author":"X Ji","year":"2013","unstructured":"Ji X, Yang W, Wang T et al (2013) Coaxially electrospun core\/shell structured poly(L-Lactide) acid\/chitosan nanofibers for potential drug carrier in tissue engineering. J Biomed Nanotechnol 9:1672\u20131678. https:\/\/doi.org\/10.1166\/jbn.2013.1665","journal-title":"J Biomed Nanotechnol"},{"key":"8419_CR28","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1166\/jbn.2014.1979","volume":"10","author":"Z Xi","year":"2014","unstructured":"Xi Z, Huang R, Deng Y, He N (2014) Progress in selection and biomedical applications of aptamers. J Biomed Nanotechnol 10:3043\u20133062. https:\/\/doi.org\/10.1166\/jbn.2014.1979","journal-title":"J Biomed Nanotechnol"},{"key":"8419_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microrna biogenesis. Nat Rev Mol Cell Biol 15:509\u2013524. https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8419_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna8010010","volume":"8","author":"AL Leit\u00e3o","year":"2022","unstructured":"Leit\u00e3o AL, Enguita FJ (2022) A structural view of MiRNA biogenesis and function. Non-coding RNA 8:10. https:\/\/doi.org\/10.3390\/ncrna8010010","journal-title":"Non-coding RNA"},{"key":"8419_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/genes13030425","volume":"13","author":"B Roy","year":"2022","unstructured":"Roy B, Lee E, Li T, Rampersaud M (2022) Role of miRNAs in neurodegeneration: from disease cause to tools of biomarker discovery and therapeutics. Genes 13:425. https:\/\/doi.org\/10.3390\/genes13030425","journal-title":"Genes"},{"key":"8419_CR32","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1016\/j.febslet.2005.07.071","volume":"579","author":"X Chen","year":"2005","unstructured":"Chen X (2005) Microrna biogenesis and function in plants. FEBS Lett 579:5923\u20135931. https:\/\/doi.org\/10.1016\/j.febslet.2005.07.071","journal-title":"FEBS Lett"},{"key":"8419_CR33","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843\u2013854. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-Y","journal-title":"Cell"},{"key":"8419_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s13238-012-2003-z","volume":"3","author":"X Chen","year":"2012","unstructured":"Chen X, Liang H, Zhang J et al (2012) Horizontal transfer of micrornas: molecular mechanisms and clinical applications. Protein Cell 3:28\u201337. https:\/\/doi.org\/10.1007\/s13238-012-2003-z","journal-title":"Protein Cell"},{"key":"8419_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11033-023-09141-6","volume":"51","author":"AA Suleiman","year":"2024","unstructured":"Suleiman AA, Al-Chalabi R, Shaban SA (2024) Integrative role of small non-coding RNAs in viral immune response: a systematic review. Mol Biol Rep 51:107. https:\/\/doi.org\/10.1007\/s11033-023-09141-6","journal-title":"Mol Biol Rep"},{"key":"8419_CR36","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.3390\/molecules19056891","volume":"19","author":"M Grasso","year":"2014","unstructured":"Grasso M, Piscopo P, Confaloni A, Denti MA (2014) Circulating miRNAs as biomarkers for neurodegenerative disorders. Molecules 19:6891\u20136910. https:\/\/doi.org\/10.3390\/molecules19056891","journal-title":"Molecules"},{"key":"8419_CR37","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S (2019) Mirbase: from microRNA sequences to function. Nucleic Acids Res 47:D155\u2013D162. https:\/\/doi.org\/10.1093\/nar\/gky1141","journal-title":"Nucleic Acids Res"},{"key":"8419_CR38","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nbt.3947","volume":"35","author":"D de Rie","year":"2017","unstructured":"de Rie D, Abugessaisa I, Alam T et al (2017) An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat Biotechnol 35:872\u2013878. https:\/\/doi.org\/10.1038\/nbt.3947","journal-title":"Nat Biotechnol"},{"key":"8419_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.emboj.7601512","volume":"26","author":"Y-K Kim","year":"2007","unstructured":"Kim Y-K, Kim VN (2007) Processing of intronic microRNAs. EMBO J 26:775\u2013783. https:\/\/doi.org\/10.1038\/sj.emboj.7601512","journal-title":"EMBO J"},{"key":"8419_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jmb.2004.03.065","volume":"339","author":"A Tanzer","year":"2004","unstructured":"Tanzer A, Stadler PF (2004) Molecular evolution of a microRNA cluster. J Mol Biol 339:327\u2013335. https:\/\/doi.org\/10.1016\/j.jmb.2004.03.065","journal-title":"J Mol Biol"},{"key":"8419_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03019-z","volume":"9","author":"W Huang","year":"2018","unstructured":"Huang W, Feng Y, Liang J et al (2018) Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration. Nat Commun 9:700. https:\/\/doi.org\/10.1038\/s41467-018-03019-z","journal-title":"Nat Commun"},{"key":"8419_CR42","doi-asserted-by":"publisher","unstructured":"Maffioletti E, Tardito D, Gennarelli M, Bocchio Chiavetto L (2014) Micro spies from the brain to the periphery: new clues from studies on MicroRNAs in neuropsychiatric disorders. Front Cell Neurosci 8. https:\/\/doi.org\/10.3389\/fncel.2014.00075","DOI":"10.3389\/fncel.2014.00075"},{"key":"8419_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","volume":"33","author":"RM O\u2019Connell","year":"2010","unstructured":"O\u2019Connell RM, Kahn D, Gibson WSJ et al (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33:607\u2013619. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.009","journal-title":"Immunity"},{"key":"8419_CR44","doi-asserted-by":"publisher","unstructured":"Denli AM, Tops BBJ, Plasterk RHA, et al (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432:231\u2013235. https:\/\/doi.org\/10.1038\/nature03049","DOI":"10.1038\/nature03049"},{"key":"8419_CR45","doi-asserted-by":"publisher","unstructured":"Alarc\u00f3n CR, Lee H, Goodarzi H, et al (2015) N6-methyladenosine marks primary microRNAs for processing. Nature 519:482\u2013485. https:\/\/doi.org\/10.1038\/nature14281","DOI":"10.1038\/nature14281"},{"key":"8419_CR46","doi-asserted-by":"publisher","unstructured":"Okada C, Yamashita E, Lee SJ et al (2009) A high-resolution structure of the pre-microRNA nuclear export machinery. Science 326:1275\u20131279. https:\/\/doi.org\/10.1126\/science.1178705","DOI":"10.1126\/science.1178705"},{"key":"8419_CR47","doi-asserted-by":"publisher","unstructured":"Zhang H, Kolb FA, Jaskiewicz L, et al (2004) Single processing center models for human dicer and bacterial RNase III. Cell 118:57\u201368. https:\/\/doi.org\/10.1016\/j.cell.2004.06.017","DOI":"10.1016\/j.cell.2004.06.017"},{"key":"8419_CR48","doi-asserted-by":"publisher","unstructured":"Yoda M, Kawamata T, Paroo Z, et al (2010) ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17:17\u201323. https:\/\/doi.org\/10.1038\/nsmb.1733","DOI":"10.1038\/nsmb.1733"},{"key":"8419_CR49","doi-asserted-by":"publisher","unstructured":"Meijer HA, Smith EM, Bushell M (2014) Regulation of miRNA strand selection: follow the leader? Biochem Soc Trans 42:1135\u20131140. https:\/\/doi.org\/10.1042\/BST20140142","DOI":"10.1042\/BST20140142"},{"key":"8419_CR50","doi-asserted-by":"publisher","unstructured":"Babiarz JE, Ruby JG, Wang Y, et al (2008) Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, dicer-dependent small RNAs. Genes Dev 22:2773\u20132785. https:\/\/doi.org\/10.1101\/gad.1705308","DOI":"10.1101\/gad.1705308"},{"key":"8419_CR51","doi-asserted-by":"publisher","unstructured":"Ruby JG, Jan CH, Bartel DP (2007) Intronic microRNA precursors that bypass drosha processing. Nature 448:83\u201386. https:\/\/doi.org\/10.1038\/nature05983","DOI":"10.1038\/nature05983"},{"key":"8419_CR52","doi-asserted-by":"publisher","unstructured":"Xie M, Li M, Vilborg A, et al (2013) Mammalian 5\u2032-capped microRNA precursors that generate a single microRNA. Cell 155:1568\u20131580. https:\/\/doi.org\/10.1016\/j.cell.2013.11.027","DOI":"10.1016\/j.cell.2013.11.027"},{"key":"8419_CR53","doi-asserted-by":"publisher","unstructured":"Yang J-S, Maurin T, Robine N, et al (2010) Conserved vertebrate mir-451 provides a platform for dicer-independent, ago2-mediated microRNA biogenesis. Proc Natl Acad Sci 107:15163\u201315168. https:\/\/doi.org\/10.1073\/pnas.1006432107","DOI":"10.1073\/pnas.1006432107"},{"key":"8419_CR54","doi-asserted-by":"publisher","unstructured":"Cheloufi S, Dos Santos CO, Chong MMW, Hannon GJ (2010) A dicer-independent miRNA biogenesis pathway that requires ago catalysis. Nature 465:584\u2013589 https:\/\/doi.org\/10.1038\/nature09092","DOI":"10.1038\/nature09092"},{"key":"8419_CR55","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/ijms20246249","volume":"20","author":"M Correia de Sousa","year":"2019","unstructured":"Correia de Sousa M, Gjorgjieva M, Dolicka D et al (2019) Deciphering mirnas\u2019 action through MiRNA editing. Int J Mol Sci 20:6249. https:\/\/doi.org\/10.3390\/ijms20246249","journal-title":"Int J Mol Sci"},{"key":"8419_CR56","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME (2018) MicroRNA. J Allergy Clin Immunol 141:1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034","journal-title":"J Allergy Clin Immunol"},{"key":"8419_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ncrna5010020","volume":"5","author":"J Godlewski","year":"2019","unstructured":"Godlewski J, Lenart J, Salinska E (2019) Microrna in brain pathology: neurodegeneration the other side of the brain cancer. Non-coding RNA 5:20. https:\/\/doi.org\/10.3390\/ncrna5010020","journal-title":"Non-coding RNA"},{"key":"8419_CR58","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S (2014) MiRBase: annotating high confidence MicroRNAs using deep sequencing data. Nucleic Acids Res 42:D68\u201373. https:\/\/doi.org\/10.1093\/nar\/gkt1181","journal-title":"Nucleic Acids Res"},{"key":"8419_CR59","doi-asserted-by":"publisher","first-page":"e79416","DOI":"10.1371\/journal.pone.0079416","volume":"8","author":"RW Freilich","year":"2013","unstructured":"Freilich RW, Woodbury ME, Ikezu T (2013) Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLoS One 8:e79416. https:\/\/doi.org\/10.1371\/journal.pone.0079416","journal-title":"PLoS One"},{"key":"8419_CR60","doi-asserted-by":"publisher","first-page":"9393","DOI":"10.1038\/s41598-019-45687-x","volume":"9","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Agostini S, Hernis A et al (2019) Circulatory miR-223-3p discriminates between parkinson\u2019s and alzheimer\u2019s patients. Sci Rep 9:9393. https:\/\/doi.org\/10.1038\/s41598-019-45687-x","journal-title":"Sci Rep"},{"key":"8419_CR61","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/mds.26457","volume":"30","author":"AG Hoss","year":"2015","unstructured":"Hoss AG, Lagomarsino VN, Frank S (2015) Study of plasma-derived miRNAs mimic differences in Huntington\u2019s disease brain. Mov Disord 30:1961\u20131964. https:\/\/doi.org\/10.1002\/mds.26457","journal-title":"Mov Disord"},{"key":"8419_CR62","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fnmol.2018.00288","volume":"11","author":"M Liguori","year":"2018","unstructured":"Liguori M, Nuzziello N, Introna A et al (2018) Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 11:288. https:\/\/doi.org\/10.3389\/fnmol.2018.00288","journal-title":"Front Mol Neurosci"},{"key":"8419_CR63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/138920209788185252","volume":"10","author":"OC Maes","year":"2009","unstructured":"Maes OC, Chertkow HM, Wang E, Schipper HM (2009) Microrna: implications for alzheimer disease and other human CNS disorders. Curr Genomics 10:154\u2013168. https:\/\/doi.org\/10.2174\/138920209788185252","journal-title":"Curr Genomics"},{"key":"8419_CR64","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1126\/science.1109020","volume":"308","author":"AJ Giraldez","year":"2005","unstructured":"Giraldez AJ, Cinalli RM, Glasner ME et al (2005) Micrornas regulate brain morphogenesis in zebrafish. Science 308:833\u2013838. https:\/\/doi.org\/10.1126\/science.1109020","journal-title":"Science"},{"key":"8419_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.1122689","volume":"312","author":"AJ Giraldez","year":"2006","unstructured":"Giraldez AJ, Mishima Y, Rihel J et al (2006) Zebrafish miR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312:75\u201379. https:\/\/doi.org\/10.1126\/science.1122689","journal-title":"Science"},{"key":"8419_CR66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molcel.2007.07.015","volume":"27","author":"EV Makeyev","year":"2007","unstructured":"Makeyev EV, Zhang J, Carrasco MA, Maniatis T (2007) The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27:435\u2013448. https:\/\/doi.org\/10.1016\/j.molcel.2007.07.015","journal-title":"Mol Cell"},{"key":"8419_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-4598-13-33","volume":"13","author":"YK Adlakha","year":"2014","unstructured":"Adlakha YK, Saini N (2014) Brain MicroRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer 13:33. https:\/\/doi.org\/10.1186\/1476-4598-13-33","journal-title":"Mol Cancer"},{"key":"8419_CR68","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04263","volume":"4","author":"E Franzoni","year":"2015","unstructured":"Franzoni E, Booker SA, Parthasarathy S et al (2015) MiR-128 regulates neuronal migration, outgrowth and intrinsic excitability via the intellectual disability gene Phf6. eLife 4:e04263. https:\/\/doi.org\/10.7554\/eLife.04263","journal-title":"eLife"},{"key":"8419_CR69","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/gtc.12809","volume":"25","author":"F Suzuki","year":"2020","unstructured":"Suzuki F, Okuno M, Tanaka T, Sanuki R (2020) Overexpression of neural miRNAs miR-9\/9* and miR-124 suppresses differentiation to M\u00fcller glia and promotes differentiation to neurons in mouse retina in vivo. Genes Cells Devoted Mol Cell Mech 25:741\u2013752. https:\/\/doi.org\/10.1111\/gtc.12809","journal-title":"Genes Cells Devoted Mol Cell Mech"},{"key":"8419_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094839","volume":"9","author":"K Burgos","year":"2014","unstructured":"Burgos K, Malenica I, Metpally R et al (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer\u2019s and Parkinson\u2019s diseases correlate with disease status and features of pathology. PLoS One 9:e94839. https:\/\/doi.org\/10.1371\/journal.pone.0094839","journal-title":"PLoS One"},{"key":"8419_CR71","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.pneurobio.2019.101664","volume":"182","author":"CA Ju\u017awik","year":"2019","unstructured":"Ju\u017awik CA, Drake S, Zhang S Y, et al (2019) MicroRNA dysregulation in neurodegenerative diseases: A systematic review. Prog Neurobiol 182:101664. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101664","journal-title":"Prog Neurobiol"},{"key":"8419_CR72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/ph13090243","volume":"13","author":"I Manna","year":"2020","unstructured":"Manna I, De Benedittis S, Quattrone A et al (2020) Exosomal miRNAs as potential diagnostic biomarkers in alzheimer\u2019s disease. Pharmaceuticals 13:243. https:\/\/doi.org\/10.3390\/ph13090243","journal-title":"Pharmaceuticals"},{"key":"8419_CR73","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.25490","volume":"85","author":"J Schulz","year":"2019","unstructured":"Schulz J, Takousis P, Wohlers I et al (2019) Meta-analyses identify differentially expressed MicroRNAs in parkinson\u2019s disease. Ann Neurol 85:835\u2013851. https:\/\/doi.org\/10.1002\/ana.25490","journal-title":"Ann Neurol"},{"key":"8419_CR74","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","volume":"33","author":"S Absalon","year":"2013","unstructured":"Absalon S, Kochanek DM, Raghavan V, Krichevsky AM (2013) MiR-26b, upregulated in alzheimer\u2019s disease, activates cell cycle entry, Tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci 33:14645\u201314659. https:\/\/doi.org\/10.1523\/JNEUROSCI.1327-13.2013","journal-title":"J Neurosci"},{"key":"8419_CR75","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1096\/fj.201801846R","volume":"33","author":"Q Qian","year":"2019","unstructured":"Qian Q, Zhang J, He F-P et al (2019) Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer\u2019s disease. FASEB J 33:4404\u20134417. https:\/\/doi.org\/10.1096\/fj.201801846R","journal-title":"FASEB J"},{"key":"8419_CR76","doi-asserted-by":"publisher","unstructured":"Akhter R, Shao Y, Shaw M, Formica S, Khrestian M et al (2018) Regulation of ADAM10 by miR-140-5p and potential relevance for alzheimer's disease. Neurobiol Aging 63:110\u2013119. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.11.007","DOI":"10.1016\/j.neurobiolaging.2017.11.007"},{"issue":"7","key":"8419_CR77","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3349\/ymj.2019.60.7.640","volume":"60","author":"S Ke","year":"2019","unstructured":"Ke S, Yang Z, Yang F et al (2019) Long noncoding RNA NEAT1 aggravates A\u03b2-induced neuronal damage by targeting miR-107 in alzheimer\u2019s disease. Yonsei Med J 60(7):640\u2013650. https:\/\/doi.org\/10.3349\/ymj.2019.60.7.640","journal-title":"Yonsei Med J"},{"key":"8419_CR78","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","volume":"28","author":"W-X Wang","year":"2008","unstructured":"Wang W-X, Rajeev BW, Stromberg AJ et al (2008) The expression of MicroRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of \u03b2-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28:1213\u20131223. https:\/\/doi.org\/10.1523\/JNEUROSCI.5065-07.2008","journal-title":"J Neurosci"},{"key":"8419_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108908","volume":"315","author":"L Sun","year":"2020","unstructured":"Sun L, Zhang T, Xiu W et al (2020) MiR-107 overexpression attenuates neurotoxicity induced by 6-hydroxydopamine both in vitro and in vivo. Chem Biol Interact 315:108908. https:\/\/doi.org\/10.1016\/j.cbi.2019.108908","journal-title":"Chem Biol Interact"},{"key":"8419_CR80","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuropharm.2016.04.046","volume":"108","author":"Y Jiao","year":"2016","unstructured":"Jiao Y, Kong L, Yao Y et al (2016) Osthole decreases beta amyloid levels through up-regulation of miR-107 in alzheimer\u2019s disease. Neuropharmacology 108:332\u2013344. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.046","journal-title":"Neuropharmacology"},{"key":"8419_CR81","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12031-019-01345-5","volume":"69","author":"M Sedighi","year":"2019","unstructured":"Sedighi M, Baluchnejadmojarad T, Fallah S et al (2019) Klotho ameliorates cellular inflammation via suppression of cytokine release and upregulation of miR-29a in the PBMCs of diagnosed alzheimer\u2019s disease patients. J Mol Neurosci 69:157\u2013165. https:\/\/doi.org\/10.1007\/s12031-019-01345-5","journal-title":"J Mol Neurosci"},{"key":"8419_CR82","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3892\/mmr.2015.3728","volume":"12","author":"G Yang","year":"2015","unstructured":"Yang G, Song Y, Zhou X et al (2015) Microrna-29c targets \u03b2-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo. Mol Med Rep 12:3081\u20133088. https:\/\/doi.org\/10.3892\/mmr.2015.3728","journal-title":"Mol Med Rep"},{"key":"8419_CR83","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS H\u00e9bert","year":"2008","unstructured":"H\u00e9bert SS, Horr\u00e9 K, Nicola\u00ef L et al (2008) Loss of MicroRNA cluster miR-29a\/b-1 in sporadic alzheimer\u2019s disease correlates with increased BACE1\/\u03b2-secretase expression. Proc Natl Acad Sci U S A 105:6415\u20136420. https:\/\/doi.org\/10.1073\/pnas.0710263105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8419_CR84","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.neurobiolaging.2013.06.007","volume":"34","author":"AM Fenn","year":"2013","unstructured":"Fenn AM, Smith KM, Lovett-Racke AE et al (2013) Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand. Neurobiol Aging 34:2748\u20132758. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.06.007","journal-title":"Neurobiol Aging"},{"key":"8419_CR85","doi-asserted-by":"publisher","first-page":"31315","DOI":"10.1074\/jbc.M805371200","volume":"283","author":"WJ Lukiw","year":"2008","unstructured":"Lukiw WJ, Zhao Y, Cui JG (2008) An NF-\u03baB-sensitive micro RNA-146a-mediated inflammatory circuit in alzheimer disease and in stressed human brain cells. J Biol Chem 283:31315\u201331322. https:\/\/doi.org\/10.1074\/jbc.M805371200","journal-title":"J Biol Chem"},{"key":"8419_CR86","doi-asserted-by":"publisher","first-page":"38951","DOI":"10.1074\/jbc.M110.178848","volume":"285","author":"JG Cui","year":"2010","unstructured":"Cui JG, Li YY, Zhao Y et al (2010) Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-\u03baB in stressed human astroglial cells and in alzheimer disease. J Biol Chem 285:38951\u201338960. https:\/\/doi.org\/10.1074\/jbc.M110.178848","journal-title":"J Biol Chem"},{"key":"8419_CR87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s11481-021-09999-y","volume":"17","author":"SJ Kim","year":"2022","unstructured":"Kim SJ, Russell AE, Wang W et al (2022) Mir-146a dysregulates energy metabolism during neuroinflammation. J Neuroimmune Pharmacol 17:228\u2013241. https:\/\/doi.org\/10.1007\/s11481-021-09999-y","journal-title":"J Neuroimmune Pharmacol"},{"key":"8419_CR88","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang K-J, Baltimore D (2006) NF-\u03baB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci 103:12481\u201312486. https:\/\/doi.org\/10.1073\/pnas.0605298103","journal-title":"Proc Natl Acad Sci"},{"key":"8419_CR89","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neuroscience.2016.12.017","volume":"344","author":"C-Z Feng","year":"2017","unstructured":"Feng C-Z, Yin J-B, Yang J-J, Cao L (2017) Regulatory factor X1 depresses ApoE-dependent A\u03b2 uptake by miRNA-124 in microglial response to oxidative stress. Neuroscience 344:217\u2013228. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.12.017","journal-title":"Neuroscience"},{"key":"8419_CR90","doi-asserted-by":"publisher","first-page":"24314","DOI":"10.18632\/oncotarget.15149","volume":"8","author":"Q Kang","year":"2017","unstructured":"Kang Q, Xiang Y, Li D et al (2017) MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K\/Akt\/GSK3\u03b2 pathway in N2a\/APP695swe cells. Oncotarget 8:24314\u201324326. https:\/\/doi.org\/10.18632\/oncotarget.15149","journal-title":"Oncotarget"},{"key":"8419_CR91","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2174\/1566524016666151123114608","volume":"15","author":"Y Kong","year":"2015","unstructured":"Kong Y, Wu J, Zhang D et al (2015) The role of miR-124 in drosophila alzheimer\u2019s disease model by targeting delta in Notch signaling pathway. Curr Mol Med 15:980\u2013989. https:\/\/doi.org\/10.2174\/1566524016666151123114608","journal-title":"Curr Mol Med"},{"key":"8419_CR92","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0963689719857085","volume":"28","author":"Q Li","year":"2019","unstructured":"Li Q, Wang Y, Peng W et al (2019) Microrna-101a regulates autophagy phenomenon via the MAPK pathway to modulate Alzheimer\u2019s-associated pathogenesis. Cell Transplant 28:1076\u20131084. https:\/\/doi.org\/10.1177\/0963689719857085","journal-title":"Cell Transplant"},{"key":"8419_CR93","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1007\/s12035-020-01957-8","volume":"57","author":"C Barbato","year":"2020","unstructured":"Barbato C, Giacovazzo G, Albiero F et al (2020) Cognitive decline and modulation of alzheimer\u2019s disease-related genes after inhibition of MicroRNA-101 in mouse hippocampal neurons. Mol Neurobiol 57:3183\u20133194. https:\/\/doi.org\/10.1007\/s12035-020-01957-8","journal-title":"Mol Neurobiol"},{"key":"8419_CR94","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","volume":"18","author":"WJ Lukiw","year":"2007","unstructured":"Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. Neuroreport 18:297\u2013300. https:\/\/doi.org\/10.1097\/WNR.0b013e3280148e8b","journal-title":"Neuroreport"},{"key":"8419_CR95","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.15252\/embj.201387576","volume":"33","author":"J Banzhaf-Strathmann","year":"2014","unstructured":"Banzhaf-Strathmann J, Benito E, May S et al (2014) Microrna-125b induces Tau hyperphosphorylation and cognitive deficits in alzheimer\u2019s disease. EMBO J 33:1667\u20131680. https:\/\/doi.org\/10.15252\/embj.201387576","journal-title":"EMBO J"},{"key":"8419_CR96","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12902","volume":"18","author":"H Tang","year":"2019","unstructured":"Tang H, Ma M, Wu Y et al (2019) Activation of MT2 receptor ameliorates dendritic abnormalities in alzheimer\u2019s disease via C\/EBP\u03b1\/miR-125b pathway. Aging Cell 18:e12902. https:\/\/doi.org\/10.1111\/acel.12902","journal-title":"Aging Cell"},{"key":"8419_CR97","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/13813455.2020.1734842","volume":"128","author":"S Madadi","year":"2022","unstructured":"Madadi S, Saidijam M, Yavari B, Soleimani M (2022) Downregulation of serum miR-106b: a potential biomarker for alzheimer disease. Arch Physiol Biochem 128:875\u2013879. https:\/\/doi.org\/10.1080\/13813455.2020.1734842","journal-title":"Arch Physiol Biochem"},{"key":"8419_CR98","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.bbrc.2016.08.037","volume":"478","author":"W Liu","year":"2016","unstructured":"Liu W, Zhao J, Lu G (2016) MiR-106b inhibits Tau phosphorylation at Tyr18 by targeting Fyn in a model of alzheimer\u2019s disease. Biochem Biophys Res Commun 478:852\u2013857. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.037","journal-title":"Biochem Biophys Res Commun"},{"key":"8419_CR99","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.expneurol.2011.11.010","volume":"235","author":"J Kim","year":"2012","unstructured":"Kim J, Yoon H, Ram\u00edrez CM et al (2012) MiR-106b impairs cholesterol efflux and increases A\u03b2 levels by repressing ABCA1 expression. Exp Neurol 235:476\u2013483. https:\/\/doi.org\/10.1016\/j.expneurol.2011.11.010","journal-title":"Exp Neurol"},{"key":"8419_CR100","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180051","volume":"38","author":"J Li","year":"2018","unstructured":"Li J, Wang H (2018) MiR-15b reduces amyloid-\u03b2 accumulation in SH-SY5Y cell line through targetting NF-\u03baB signaling and BACE1. Biosci Rep 38:BSR20180051. https:\/\/doi.org\/10.1042\/BSR20180051","journal-title":"Biosci Rep"},{"issue":"9","key":"8419_CR101","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.4103\/1673-5374.255979","volume":"14","author":"H-Y Liu","year":"2019","unstructured":"Liu H-Y, Fu X, Li Y-F et al (2019) MiR-15b-5p targeting amyloid precursor protein is involved in the anti-amyloid eflect of Curcumin in swAPP695-HEK293 cells. Neural Regen Res 14:1603. https:\/\/doi.org\/10.4103\/1673-5374.255979","journal-title":"Neural Regen Res"},{"key":"8419_CR102","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fphar.2019.00806","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang L, Liu J, Wang Q et al (2019) Microrna-200a-3p mediates neuroprotection in Alzheimer-related deficits and attenuates Amyloid-Beta overproduction and Tau hyperphosphorylation via coregulating BACE1 and PRKACB. Front Pharmacol 10:806. https:\/\/doi.org\/10.3389\/fphar.2019.00806","journal-title":"Front Pharmacol"},{"key":"8419_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196929","volume":"13","author":"S Higaki","year":"2018","unstructured":"Higaki S, Muramatsu M, Matsuda A et al (2018) Defensive effect of microRNA-200b\/c against amyloid-beta peptide-induced toxicity in Alzheimer\u2019s disease models. PLoS One 13:e0196929. https:\/\/doi.org\/10.1371\/journal.pone.0196929","journal-title":"PLoS One"},{"key":"8419_CR104","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.omtn.2020.01.010","volume":"19","author":"AT Barros-Viegas","year":"2020","unstructured":"Barros-Viegas AT, Carmona V, Ferreiro E et al (2020) MiRNA-31 improves cognition and abolishes Amyloid-\u03b2 pathology by targeting APP and BACE1 in an animal model of alzheimer\u2019s disease. Mol Ther 19:1219\u20131236. https:\/\/doi.org\/10.1016\/j.omtn.2020.01.010","journal-title":"Mol Ther"},{"key":"8419_CR105","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1074\/jbc.M807530200","volume":"284","author":"V Boissonneault","year":"2009","unstructured":"Boissonneault V, Plante I, Rivest S, Provost P (2009) Microrna-298 and microrna-328 regulate expression of mouse \u03b2-amyloid precursor protein-converting enzyme 1 *. J Biol Chem 284:1971\u20131981. https:\/\/doi.org\/10.1074\/jbc.M807530200","journal-title":"J Biol Chem"},{"key":"8419_CR106","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.biopha.2018.02.043","volume":"101","author":"M-G Feng","year":"2018","unstructured":"Feng M-G, Liu C-F, Chen L et al (2018) MiR-21 attenuates apoptosis-triggered by amyloid-\u03b2 via modulating PDCD4\/ PI3K\/AKT\/GSK-3\u03b2 pathway in SH-SY5Y cells. Biomed Pharmacother 101:1003\u20131007. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.043","journal-title":"Biomed Pharmacother"},{"key":"8419_CR107","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12918-018-0633-3","volume":"12","author":"L Hu","year":"2018","unstructured":"Hu L, Zhang R, Yuan Q et al (2018) The emerging role of microRNA-4487\/6845-3p in alzheimer\u2019s disease pathologies is induced by A\u03b225\u201335 triggered in SH-SY5Y cell. BMC Syst Biol 12:119. https:\/\/doi.org\/10.1186\/s12918-018-0633-3","journal-title":"BMC Syst Biol"},{"key":"8419_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02728-9","volume":"22","author":"L He","year":"2022","unstructured":"He L, Chen Z, Wang J, Feng H (2022) Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer\u2019s disease. BMC Neurol 22:203. https:\/\/doi.org\/10.1186\/s12883-022-02728-9","journal-title":"BMC Neurol"},{"key":"8419_CR109","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13125","volume":"19","author":"Z Shi","year":"2020","unstructured":"Shi Z, Zhang K, Zhou H et al (2020) Increased miR-34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS-JNK-p53 pathway in alzheimer\u2019s disease. Aging Cell 19:e13125. https:\/\/doi.org\/10.1111\/acel.13125","journal-title":"Aging Cell"},{"key":"8419_CR110","doi-asserted-by":"publisher","unstructured":"Song J, Kim Y-K (2017) Identification of the role of miR-142-5p in alzheimer\u2019s disease by comparative bioinformatics and cellular analysis. Front Mol Neurosci 10:227. https:\/\/doi.org\/10.3389\/fnmol.2017.00227","DOI":"10.3389\/fnmol.2017.00227"},{"key":"8419_CR111","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-190743","volume":"71","author":"H Xu","year":"2019","unstructured":"Xu H, Yue C, Chen L (2019) Post-transcriptional regulation of soluble guanylate cyclase that governs neuropathic pain in Alzheimer\u2019s disease. J Alzheimers Dis 71:1331\u20131338. https:\/\/doi.org\/10.3233\/JAD-190743","journal-title":"J Alzheimers Dis"},{"key":"8419_CR112","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.febslet.2015.02.001","volume":"589","author":"X Wang","year":"2015","unstructured":"Wang X, Tan L, Lu Y et al (2015) Microrna-138 promotes Tau phosphorylation by targeting retinoic acid receptor alpha. FEBS Lett 589:726\u2013729. https:\/\/doi.org\/10.1016\/j.febslet.2015.02.001","journal-title":"FEBS Lett"},{"key":"8419_CR113","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neurobiolaging.2016.12.015","volume":"51","author":"Y Wang","year":"2017","unstructured":"Wang Y, Veremeyko T, Wong AH-K et al (2017) Downregulation of miR-132\/212 impairs S-nitrosylation balance and induces Tau phosphorylation in alzheimer\u2019s disease. Neurobiol Aging 51:156\u2013166. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.12.015","journal-title":"Neurobiol Aging"},{"key":"8419_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11166","volume":"23","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xu Y, Yu M (2022) MicroRNA\u20134722\u20135p and microRNA\u2013615\u20133p serve as potential biomarkers for alzheimer\u2019s disease. Exp Ther Med 23:1\u201310. https:\/\/doi.org\/10.3892\/etm.2022.11166","journal-title":"Exp Ther Med"},{"key":"8419_CR115","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000430356","volume":"37","author":"Z Liu","year":"2015","unstructured":"Liu Z, Wang C, Wang X, Xu S (2015) Therapeutic effects of transplantation of As-MiR-937-expressing mesenchymal stem cells in murine model of alzheimer\u2019s disease. Cell Physiol Biochem 37:321\u2013330. https:\/\/doi.org\/10.1159\/000430356","journal-title":"Cell Physiol Biochem"},{"key":"8419_CR116","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroscience.2014.06.013","volume":"275","author":"Z-B Zhao","year":"2014","unstructured":"Zhao Z-B, Wu L, Xiong R et al (2014) Microrna-922 promotes Tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of alzheimer\u2019s disease. Neuroscience 275:232\u2013237. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.06.013","journal-title":"Neuroscience"},{"key":"8419_CR117","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3233\/JAD-180201","volume":"64","author":"IHK Dias","year":"2018","unstructured":"Dias IHK, Brown CL, Shabir K et al (2018) Mirna 933 expression by endothelial cells is increased by 27-hydroxycholesterol and is more prevalent in plasma from dementia patients. J Alzheimers Dis 64:1009\u20131017. https:\/\/doi.org\/10.3233\/JAD-180201","journal-title":"J Alzheimers Dis"},{"key":"8419_CR118","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12031-011-9587-2","volume":"46","author":"N Schonrock","year":"2012","unstructured":"Schonrock N, Humphreys DT, Preiss T, G\u00f6tz J (2012) Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by Amyloid-\u03b2. J Mol Neurosci 46:324\u2013335. https:\/\/doi.org\/10.1007\/s12031-011-9587-2","journal-title":"J Mol Neurosci"},{"key":"8419_CR119","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000492844","volume":"49","author":"P Liu","year":"2018","unstructured":"Liu P, Liu P, Wang Z et al (2018) Inhibition of microRNA-96 ameliorates cognitive impairment and inactivation autophagy following chronic cerebral hypoperfusion in the rat. Cell Physiol Biochem 49:78\u201386. https:\/\/doi.org\/10.1159\/000492844","journal-title":"Cell Physiol Biochem"},{"key":"8419_CR120","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/1061186X.2021.1886300","volume":"29","author":"X Qin","year":"2021","unstructured":"Qin X, Zhang X, Li P et al (2021) Microrna-185 activates PI3K\/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in parkinson\u2019s disease. J Drug Target 29:875\u2013883. https:\/\/doi.org\/10.1080\/1061186X.2021.1886300","journal-title":"J Drug Target"},{"key":"8419_CR121","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jchemneu.2011.01.005","volume":"42","author":"MM Harraz","year":"2011","unstructured":"Harraz MM, Dawson TM, Dawson VL (2011) Micrornas in parkinson\u2019s disease. J Chem Neuroanat 42:127\u2013130. https:\/\/doi.org\/10.1016\/j.jchemneu.2011.01.005","journal-title":"J Chem Neuroanat"},{"key":"8419_CR122","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of \u03b1-synuclein expression by mir-7 and mir-153. J Biol Chem 285:12726\u201312734. https:\/\/doi.org\/10.1074\/jbc.M109.086827","journal-title":"J Biol Chem"},{"key":"8419_CR123","first-page":"993","volume":"8","author":"S Li","year":"2016","unstructured":"Li S, Lv X, Zhai K et al (2016) MicroRNA-7 inhibits neuronal apoptosis in a cellular parkinson\u2019s disease model by targeting Bax and Sirt2. Am J Transl Res 8:993\u20131004","journal-title":"Am J Transl Res"},{"key":"8419_CR124","unstructured":"Zhu J, Wang S, Qi W et al (2018) Overexpression of miR-153 promotes oxidative stress in MPP+-induced PD model by negatively regulating the Nrf2\/HO-1 signaling pathway. Int J Clin Exp Pathol 11:4179\u20134187."},{"key":"8419_CR125","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature09191","volume":"466","author":"S Gehrke","year":"2010","unstructured":"Gehrke S, Imai Y, Sokol N, Lu B (2010) Pathogenic LRRK2 negatively regulates microrna-mediated translational repression. Nature 466:637\u2013641. https:\/\/doi.org\/10.1038\/nature09191","journal-title":"Nature"},{"key":"8419_CR126","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.febslet.2014.12.014","volume":"589","author":"S Kabaria","year":"2015","unstructured":"Kabaria S, Choi DC, Chaudhuri AD et al (2015) Inhibition of miR-34b and miR-34c enhances \u03b1-synuclein expression in parkinson\u2019s disease. FEBS Lett 589:319\u2013325. https:\/\/doi.org\/10.1016\/j.febslet.2014.12.014","journal-title":"FEBS Lett"},{"key":"8419_CR127","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","volume":"82","author":"G Wang","year":"2008","unstructured":"Wang G, van der Walt JM, Mayhew G et al (2008) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 82:283\u2013289. https:\/\/doi.org\/10.1016\/j.ajhg.2007.09.021","journal-title":"Am J Hum Genet"},{"key":"8419_CR128","doi-asserted-by":"publisher","unstructured":"Serafin A, Foco L, Zanigni S et al (2015) Overexpression of blood microRNAs 103a, 30b, and 29a in l-dopa\u2013treated patients with PD. Neurology 84:645\u2013653. https:\/\/doi.org\/10.1212\/WNL.0000000000001258","DOI":"10.1212\/WNL.0000000000001258"},{"key":"8419_CR129","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jbiotec.2011.01.023","volume":"152","author":"R Margis","year":"2011","unstructured":"Margis R, Margis R, Rieder CRM (2011) Identification of blood microRNAs associated to parkinson\u2019s disease. J Biotechnol 152:96\u2013101. https:\/\/doi.org\/10.1016\/j.jbiotec.2011.01.023","journal-title":"J Biotechnol"},{"key":"8419_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0121-4","volume":"11","author":"J Kim","year":"2016","unstructured":"Kim J, Fiesel FC, Belmonte KC et al (2016) MiR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Mol Neurodegener 11:55. https:\/\/doi.org\/10.1186\/s13024-016-0121-4","journal-title":"Mol Neurodegener"},{"key":"8419_CR131","doi-asserted-by":"publisher","unstructured":"Sun S, Han X, Li X et al (2018) Microrna-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of parkinson\u2019s disease. Front Mol Neurosci 11:381. https:\/\/doi.org\/10.3389\/fnmol.2018.00381","DOI":"10.3389\/fnmol.2018.00381"},{"key":"8419_CR132","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/hmg\/dds470","volume":"22","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Liu G, Jin SM et al (2013) Microrna-205 regulates the expression of parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22:608\u2013620. https:\/\/doi.org\/10.1093\/hmg\/dds470","journal-title":"Hum Mol Genet"},{"key":"8419_CR133","doi-asserted-by":"publisher","first-page":"724","DOI":"10.26355\/eurrev_201901_16886","volume":"23","author":"Q Wu","year":"2019","unstructured":"Wu Q, Xi D-Z, Wang Y-H (2019) Microrna-599 regulates the development of parkinson\u2019s disease through mediating LRRK2 expression. Eur Rev Med Pharmacol Sci 23:724\u2013731. https:\/\/doi.org\/10.26355\/eurrev_201901_16886","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8419_CR134","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10571-014-0126-x","volume":"35","author":"H Zou","year":"2015","unstructured":"Zou H, Ding Y, Shi W et al (2015) Microrna-29c\/PTEN pathway is involved in mice brain development and modulates neurite outgrowth in PC12 cells. Cell Mol Neurobiol 35:313\u2013322. https:\/\/doi.org\/10.1007\/s10571-014-0126-x","journal-title":"Cell Mol Neurobiol"},{"key":"8419_CR135","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2016.05.011","volume":"1644","author":"C Su","year":"2016","unstructured":"Su C, Yang X, Lou J (2016) Geniposide reduces \u03b1-synuclein by blocking microrna-21\/lysosome-associated membrane protein 2a interaction in Parkinson disease models. Brain Res 1644:98\u2013106. https:\/\/doi.org\/10.1016\/j.brainres.2016.05.011","journal-title":"Brain Res"},{"key":"8419_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107900","volume":"164","author":"RM Salama","year":"2020","unstructured":"Salama RM, Abdel-Latif GA, Abbas SS et al (2020) Neuroprotective effect of Crocin against rotenone-induced parkinson\u2019s disease in rats: interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221. Neuropharmacology 164:107900. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107900","journal-title":"Neuropharmacology"},{"key":"8419_CR137","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yexmp.2019.05.002","volume":"109","author":"H Ge","year":"2019","unstructured":"Ge H, Yan Z, Zhu H, Zhao H (2019) Mir-410 exerts neuroprotective effects in a cellular model of parkinson\u2019s disease induced by 6-hydroxydopamine via inhibiting the pten\/akt\/mtor signaling pathway. Exp Mol Pathol 109:16\u201324. https:\/\/doi.org\/10.1016\/j.yexmp.2019.05.002","journal-title":"Exp Mol Pathol"},{"key":"8419_CR138","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jocn.2019.08.082","volume":"70","author":"L Qin","year":"2019","unstructured":"Qin L, Tan J, Zhang H et al (2019) Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of parkinson\u2019s disease patients. J Clin Neurosci 70:198\u2013201. https:\/\/doi.org\/10.1016\/j.jocn.2019.08.082","journal-title":"J Clin Neurosci"},{"key":"8419_CR139","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/ijmm.2018.3982","volume":"43","author":"J-X Gao","year":"2019","unstructured":"Gao J-X, Li Y, Wang S-N et al (2019) Overexpression of microRNA-183 promotes apoptosis of substantia Nigra neurons via the Inhibition of OSMR in a mouse model of parkinson\u2019s disease. Int J Mol Med 43:209\u2013220. https:\/\/doi.org\/10.3892\/ijmm.2018.3982","journal-title":"Int J Mol Med"},{"key":"8419_CR140","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejphar.2018.07.023","volume":"835","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wang S, Liang Y, Xu X (2018) Inhibition of microRNA-505 suppressed MPP+ -induced cytotoxicity of SHSY5Y cells in an in vitro parkinson\u2019s disease model. Eur J Pharmacol 835:11\u201318. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.023","journal-title":"Eur J Pharmacol"},{"key":"8419_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1567","volume":"10","author":"Y Shen","year":"2020","unstructured":"Shen Y, Zhu Z, Qian S et al (2020) Mir-30b protects nigrostriatal dopaminergic neurons from MPP(+)-induced neurotoxicity via SNCA. Brain Behav 10:e01567. https:\/\/doi.org\/10.1002\/brb3.1567","journal-title":"Brain Behav"},{"key":"8419_CR142","doi-asserted-by":"publisher","first-page":"e0137637","DOI":"10.1371\/journal.pone.0137637","volume":"10","author":"M-H Fu","year":"2015","unstructured":"Fu M-H, Li C-L, Lin H-L et al (2015) The potential regulatory mechanisms of miR-196a in huntington\u2019s disease through bioinformatic analyses. PLoS One 10:e0137637. https:\/\/doi.org\/10.1371\/journal.pone.0137637","journal-title":"PLoS One"},{"key":"8419_CR143","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ et al (2008) The bifunctional MicroRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci 28:14341\u201314346. https:\/\/doi.org\/10.1523\/JNEUROSCI.2390-08.2008","journal-title":"J Neurosci"},{"key":"8419_CR144","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","volume":"11","author":"R Johnson","year":"2009","unstructured":"Johnson R, Buckley NJ (2009) Gene dysregulation in huntington\u2019s disease: REST, microRNAs and beyond. Neuromolecular Med 11:183\u2013199. https:\/\/doi.org\/10.1007\/s12017-009-8063-4","journal-title":"Neuromolecular Med"},{"key":"8419_CR145","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-6606-7-46","volume":"7","author":"J Kocerha","year":"2014","unstructured":"Kocerha J, Xu Y, Prucha MS et al (2014) MicroRNA-128a dysregulation in transgenic huntington\u2019s disease monkeys. Mol Brain 7:46. https:\/\/doi.org\/10.1186\/1756-6606-7-46","journal-title":"Mol Brain"},{"key":"8419_CR146","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mcn.2017.12.009","volume":"88","author":"RH Reynolds","year":"2018","unstructured":"Reynolds RH, Petersen MH, Willert CW et al (2018) Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 huntington\u2019s disease model. Mol Cell Neurosci 88:118\u2013129. https:\/\/doi.org\/10.1016\/j.mcn.2017.12.009","journal-title":"Mol Cell Neurosci"},{"key":"8419_CR147","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.omtn.2018.01.007","volume":"11","author":"M Fukuoka","year":"2018","unstructured":"Fukuoka M, Takahashi M, Fujita H et al (2018) Supplemental treatment for huntington\u2019s disease with miR-132 that is deficient in huntington\u2019s disease brain. Mol Ther - Nucleic Acids 11:79\u201390. https:\/\/doi.org\/10.1016\/j.omtn.2018.01.007","journal-title":"Mol Ther - Nucleic Acids"},{"key":"8419_CR148","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1126\/science.1181046","volume":"326","author":"AH Williams","year":"2009","unstructured":"Williams AH, Valdez G, Moresi V et al (2009) Microrna-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326:1549\u20131554. https:\/\/doi.org\/10.1126\/science.1181046","journal-title":"Science"},{"key":"8419_CR149","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","volume":"22","author":"ED Koval","year":"2013","unstructured":"Koval ED, Shaner C, Zhang P et al (2013) Method for widespread microRNA-155 Inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22:4127\u20134135. https:\/\/doi.org\/10.1093\/hmg\/ddt261","journal-title":"Hum Mol Genet"},{"key":"8419_CR150","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2018.10.032","volume":"1706","author":"ZCE Hawley","year":"2019","unstructured":"Hawley ZCE, Campos-Melo D, Strong MJ (2019) MiR-105 and miR-9 regulate the mRNA stability of neuronal intermediate filaments. Implications for the pathogenesis of amyotrophic lateral sclerosis (ALS). Brain Res 1706:93\u2013100. https:\/\/doi.org\/10.1016\/j.brainres.2018.10.032","journal-title":"Brain Res"},{"key":"8419_CR151","first-page":"231","volume-title":"Handbook of Clinical Neurology","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonz\u00e1lez HM, L\u00e9ger GC (2019) Chap. 13 - Alzheimer\u2019s disease. In: Dekosky ST, Asthana S (eds) Handbook of Clinical Neurology. Elsevier, pp 231\u2013255"},{"key":"8419_CR152","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","volume":"103","author":"A Atri","year":"2019","unstructured":"Atri A (2019) The alzheimer\u2019s disease clinical spectrum: diagnosis and management. Med Clin North Am 103:263\u2013293. https:\/\/doi.org\/10.1016\/j.mcna.2018.10.009","journal-title":"Med Clin North Am"},{"key":"8419_CR153","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","volume":"19","author":"L Crews","year":"2010","unstructured":"Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in alzheimer\u2019s disease. Hum Mol Genet 19:R12\u2013R20. https:\/\/doi.org\/10.1093\/hmg\/ddq160","journal-title":"Hum Mol Genet"},{"key":"8419_CR154","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12:719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheimers Dement"},{"key":"8419_CR155","doi-asserted-by":"crossref","unstructured":"Quinlan S, Kenny A, Medina M et al (2017) Chapter seven - MicroRNAs in neurodegenerative diseases. In: Galluzzi L, Vitale I (eds) International review of cell and molecular biology. Academic Press, pp 309\u2013343","DOI":"10.1016\/bs.ircmb.2017.04.002"},{"key":"8419_CR156","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainres.2010.03.106","volume":"1338","author":"K-C Sonntag","year":"2010","unstructured":"Sonntag K-C (2010) Micrornas and deregulated gene expression networks in neurodegeneration. Brain Res 1338:48\u201357. https:\/\/doi.org\/10.1016\/j.brainres.2010.03.106","journal-title":"Brain Res"},{"key":"8419_CR157","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","volume":"39","author":"S Li","year":"2023","unstructured":"Li S, Lei Z, Sun T (2023) The role of MicroRNAs in neurodegenerative diseases: a review. Cell Biol Toxicol 39:53\u201383. https:\/\/doi.org\/10.1007\/s10565-022-09761-x","journal-title":"Cell Biol Toxicol"},{"key":"8419_CR158","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"A Association","year":"2016","unstructured":"Association A (2016) 2016 alzheimer\u2019s disease facts and figures. Alzheimers Dement 12:459\u2013509. https:\/\/doi.org\/10.1016\/j.jalz.2016.03.001","journal-title":"Alzheimers Dement"},{"key":"8419_CR159","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102:13944\u201313949. https:\/\/doi.org\/10.1073\/pnas.0506654102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8419_CR160","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","volume":"10","author":"Y-B Hu","year":"2019","unstructured":"Hu Y-B, Zhang Y-F, Wang H et al (2019) MiR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in parkinson\u2019s disease. Cell Death Dis 10:589. https:\/\/doi.org\/10.1038\/s41419-019-1809-5","journal-title":"Cell Death Dis"},{"key":"8419_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010712","volume":"24","author":"M Salemi","year":"2022","unstructured":"Salemi M, Marchese G, Lanza G et al (2022) Role and dysregulation of miRNA in patients with parkinson\u2019s disease. Int J Mol Sci 24:712. https:\/\/doi.org\/10.3390\/ijms24010712","journal-title":"Int J Mol Sci"},{"key":"8419_CR162","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/ejn.16207","volume":"59","author":"MY Zamanian","year":"2024","unstructured":"Zamanian MY, Ivraghi MS, Gupta R et al (2024) MiR-221 and parkinson\u2019s disease: a biomarker with therapeutic potential. Eur J Neurosci 59:283\u2013297. https:\/\/doi.org\/10.1111\/ejn.16207","journal-title":"Eur J Neurosci"},{"key":"8419_CR163","doi-asserted-by":"publisher","unstructured":"Heman-Ackah SM, Hallegger M, Rao M, Wood M (2013) RISC in PD: the impact of MicroRNAs in parkinson\u2019s disease cellular and molecular pathogenesis. Front Mol Neurosci 6. https:\/\/doi.org\/10.3389\/fnmol.2013.00040","DOI":"10.3389\/fnmol.2013.00040"},{"key":"8419_CR164","doi-asserted-by":"publisher","first-page":"744942","DOI":"10.3389\/fnmol.2021.744942","volume":"14","author":"S Li","year":"2022","unstructured":"Li S, Bi G, Han S, Huang R (2022) Micrornas play a role in parkinson\u2019s disease by regulating microglia function: from pathogenetic involvement to therapeutic potential. Front Mol Neurosci 14:744942. https:\/\/doi.org\/10.3389\/fnmol.2021.744942","journal-title":"Front Mol Neurosci"},{"key":"8419_CR165","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"},{"key":"8419_CR166","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Petre BM, Wall J et al (2002) \u0391-Synuclein, especially the parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322:1089\u20131102. https:\/\/doi.org\/10.1016\/S0022-2836(02)00735-0","journal-title":"J Mol Biol"},{"key":"8419_CR167","doi-asserted-by":"publisher","unstructured":"Recasens A, Perier C, Sue CM (2016) Role of MicroRNAs in the regulation of \u03b1-Synuclein expression: a systematic review. Front Mol Neurosci 9. https:\/\/doi.org\/10.3389\/fnmol.2016.00128","DOI":"10.3389\/fnmol.2016.00128"},{"key":"8419_CR168","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/gm213","volume":"2","author":"J-L Dreyer","year":"2010","unstructured":"Dreyer J-L (2010) New insights into the roles of MicroRNAs in drug addiction and neuroplasticity. Genome Med 2:92. https:\/\/doi.org\/10.1186\/gm213","journal-title":"Genome Med"},{"key":"8419_CR169","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3841","volume":"16","author":"PG Higgs","year":"2015","unstructured":"Higgs PG, Lehman N (2015) The RNA world: molecular cooperation at the origins of life. Nat Rev Genet 16:7\u201317. https:\/\/doi.org\/10.1038\/nrg3841","journal-title":"Nat Rev Genet"},{"key":"8419_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225649","volume":"20","author":"SY Goh","year":"2019","unstructured":"Goh SY, Chao YX, Dheen ST et al (2019) Role of MicroRNAs in parkinson\u2019s disease. Int J Mol Sci 20:5649. https:\/\/doi.org\/10.3390\/ijms20225649","journal-title":"Int J Mol Sci"},{"key":"8419_CR171","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2017.09.065","volume":"661","author":"G Je","year":"2017","unstructured":"Je G, Kim Y-S (2017) Mitochondrial ROS-mediated post-transcriptional regulation of \u03b1-synuclein through miR-7 and miR-153. Neurosci Lett 661:132\u2013136. https:\/\/doi.org\/10.1016\/j.neulet.2017.09.065","journal-title":"Neurosci Lett"},{"key":"8419_CR172","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/mgg3.469","volume":"6","author":"Z Shanesazzade","year":"2018","unstructured":"Shanesazzade Z, Peymani M, Ghaedi K, Nasr Esfahani MH (2018) MiR-34a\/BCL\u20102 signaling axis contributes to apoptosis in MPP+\u2010induced SH\u2010SY5Y cells. Mol Genet Genomic Med 6:975\u2013981. https:\/\/doi.org\/10.1002\/mgg3.469","journal-title":"Mol Genet Genomic Med"},{"key":"8419_CR173","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12035-020-02101-2","volume":"58","author":"C Eyileten","year":"2021","unstructured":"Eyileten C, Sharif L, Wicik Z et al (2021) The relation of the brain-derived neurotrophic factor with MicroRNAs in neurodegenerative diseases and ischemic stroke. Mol Neurobiol 58:329\u2013347. https:\/\/doi.org\/10.1007\/s12035-020-02101-2","journal-title":"Mol Neurobiol"},{"key":"8419_CR174","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2015.05.021","volume":"1618","author":"CE Briggs","year":"2015","unstructured":"Briggs CE, Wang Y, Kong B et al (2015) Midbrain dopamine neurons in parkinson\u05f3s disease exhibit a dysregulated MiRNA and target-gene network. Brain Res 1618:111\u2013121. https:\/\/doi.org\/10.1016\/j.brainres.2015.05.021","journal-title":"Brain Res"},{"key":"8419_CR175","doi-asserted-by":"publisher","first-page":"16272","DOI":"10.1038\/s41598-023-43096-9","volume":"13","author":"D Gu\u00e9vremont","year":"2023","unstructured":"Gu\u00e9vremont D, Roy J, Cutfield NJ, Williams JM (2023) Micrornas in parkinson\u2019s disease: a systematic review and diagnostic accuracy meta-analysis. Sci Rep 13:16272. https:\/\/doi.org\/10.1038\/s41598-023-43096-9","journal-title":"Sci Rep"},{"key":"8419_CR176","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/bios12121074","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen Z, Chen H et al (2022) Recent advances in the roles of microRNA and microRNA-based diagnosis in neurodegenerative diseases. Biosensors 12:1074. https:\/\/doi.org\/10.3390\/bios12121074","journal-title":"Biosensors"},{"key":"8419_CR177","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","volume":"22","author":"H Ding","year":"2016","unstructured":"Ding H, Huang Z, Chen M et al (2016) Identification of a panel of five serum miRNAs as a biomarker for parkinson\u2019s disease. Parkinsonism Relat Disord 22:68\u201373. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.11.014","journal-title":"Parkinsonism Relat Disord"},{"key":"8419_CR178","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0393-21.2021","volume":"9","author":"X Gong","year":"2022","unstructured":"Gong X, Huang M, Chen L (2022) Mechanism of miR-132-3p promoting neuroinflammation and dopaminergic neurodegeneration in parkinson\u2019s disease. eNeuro 9:ENEURO.0393-21.2021. https:\/\/doi.org\/10.1523\/ENEURO.0393-21.2021","journal-title":"eNeuro"},{"key":"8419_CR179","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3892\/mmr.2017.7897","volume":"17","author":"Z Wen","year":"2018","unstructured":"Wen Z, Zhang J, Tang P et al (2018) Overexpression of miR\u2013185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the ampk\/mtor signaling pathway in parkinson\u2019s disease. Mol Med Rep 17:131\u2013137. https:\/\/doi.org\/10.3892\/mmr.2017.7897","journal-title":"Mol Med Rep"},{"key":"8419_CR180","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG (2016) Microrna-155 regulates Alpha-Synuclein-Induced inflammatory responses in models of Parkinson disease. J Neurosci 36:2383\u20132390. https:\/\/doi.org\/10.1523\/JNEUROSCI.3900-15.2016","journal-title":"J Neurosci"},{"key":"8419_CR181","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"K Kieburtz","year":"1996","unstructured":"Kieburtz K, Penney JB, Como P et al (1996) Unified huntington\u2019s disease rating scale: reliability and consistency. Mov Disord 11:136\u2013142. https:\/\/doi.org\/10.1002\/mds.870110204","journal-title":"Mov Disord"},{"key":"8419_CR182","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington\u2019s disease chromosomes. Cell 72:971\u2013983. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E","journal-title":"Cell"},{"key":"8419_CR183","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25:24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"key":"8419_CR184","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nbd.2010.02.003","volume":"39","author":"NJ Buckley","year":"2010","unstructured":"Buckley NJ, Johnson R, Zuccato C et al (2010) The role of REST in transcriptional and epigenetic dysregulation in huntington\u2019s disease. Neurobiol Dis 39:28\u201339. https:\/\/doi.org\/10.1016\/j.nbd.2010.02.003","journal-title":"Neurobiol Dis"},{"key":"8419_CR185","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.conb.2017.12.008","volume":"48","author":"J-Y Hwang","year":"2018","unstructured":"Hwang J-Y, Zukin RS (2018) REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol 48:193\u2013200. https:\/\/doi.org\/10.1016\/j.conb.2017.12.008","journal-title":"Curr Opin Neurobiol"},{"key":"8419_CR186","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14802\/jmd.16054","volume":"10","author":"S-T Lee","year":"2017","unstructured":"Lee S-T, Im W, Ban J-J et al (2017) Exosome-based delivery of miR-124 in a huntington\u2019s disease model. Journal of Movement Disorders 10:45\u201352. https:\/\/doi.org\/10.14802\/jmd.16054","journal-title":"Journal of Movement Disorders"},{"key":"8419_CR187","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature10323","volume":"476","author":"AS Yoo","year":"2011","unstructured":"Yoo AS, Sun AX, Li L et al (2011) Microrna-mediated conversion of human fibroblasts to neurons. Nature 476:228\u2013231. https:\/\/doi.org\/10.1038\/nature10323","journal-title":"Nature"},{"key":"8419_CR188","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-017-0742-x","volume":"12","author":"K-H Chang","year":"2017","unstructured":"Chang K-H, Wu Y-R, Chen C-M (2017) Down-regulation of miR-9* in the peripheral leukocytes of huntington\u2019s disease patients. Orphanet J Rare Dis 12:185. https:\/\/doi.org\/10.1186\/s13023-017-0742-x","journal-title":"Orphanet J Rare Dis"},{"key":"8419_CR189","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/mds.26457","volume":"30","author":"AG Hoss","year":"2015","unstructured":"Hoss AG, Lagomarsino VN, Frank S et al (2015) Study of plasma-derived miRNAs mimic differences in Huntington\u2019s disease brain. Mov Disord 30:1961\u20131964. https:\/\/doi.org\/10.1002\/mds.26457","journal-title":"Mov Disord"},{"key":"8419_CR190","doi-asserted-by":"publisher","unstructured":"Hoss AG, Labadorf A, Beach TG et al (2016) MicroRNA profiles in parkinson\u2019s disease prefrontal cortex. Front Aging Neurosci 8:36. https:\/\/doi.org\/10.3389\/fnagi.2016.00036","DOI":"10.3389\/fnagi.2016.00036"},{"key":"8419_CR191","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12920-015-0083-3","volume":"8","author":"AG Hoss","year":"2015","unstructured":"Hoss AG, Labadorf A, Latourelle JC et al (2015) MiR-10b-5p expression in huntington\u2019s disease brain relates to age of onset and the extent of striatal involvement. BMC Med Genomics 8:10. https:\/\/doi.org\/10.1186\/s12920-015-0083-3","journal-title":"BMC Med Genomics"},{"key":"8419_CR192","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.4103\/1673-5374.310673","volume":"16","author":"B Martinez","year":"2021","unstructured":"Martinez B, Peplow PV (2021) Altered microRNA expression in animal models of huntington\u2019s disease and potential therapeutic strategies. Neural Regen Res 16:2159\u20132169. https:\/\/doi.org\/10.4103\/1673-5374.310673","journal-title":"Neural Regen Res"},{"key":"8419_CR193","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3233\/JAD-150395","volume":"48","author":"HK Karnati","year":"2015","unstructured":"Karnati HK, Panigrahi MK, Gutti RK et al (2015) miRNAs: key players in neurodegenerative disorders and epilepsy. J Alzheimers Dis 48:563\u2013580. https:\/\/doi.org\/10.3233\/JAD-150395","journal-title":"J Alzheimers Dis"},{"key":"8419_CR194","doi-asserted-by":"publisher","unstructured":"Sharma S, Lu HC (2018) Micrornas in neurodegeneration: current findings and potential impacts. J Alzheimers Dis Parkinsonism 08. https:\/\/doi.org\/10.4172\/2161-0460.1000420","DOI":"10.4172\/2161-0460.1000420"},{"key":"8419_CR195","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","volume":"93","author":"P-H Cheng","year":"2013","unstructured":"Cheng P-H, Li C-L, Chang Y-F et al (2013) Mir-196a ameliorates phenotypes of huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models. Am J Hum Genet 93:306\u2013312. https:\/\/doi.org\/10.1016\/j.ajhg.2013.05.025","journal-title":"Am J Hum Genet"},{"key":"8419_CR196","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.7150\/thno.18813","volume":"7","author":"L-S Her","year":"2017","unstructured":"Her L-S, Mao S-H, Chang C-Y et al (2017) MiR-196a enhances neuronal morphology through suppressing RANBP10 to provide neuroprotection in huntington\u2019s disease. Theranostics 7:2452\u20132462. https:\/\/doi.org\/10.7150\/thno.18813","journal-title":"Theranostics"},{"key":"8419_CR197","doi-asserted-by":"publisher","unstructured":"Koike Y, Onodera O (2023) Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: challenging for clinical applications. Front Neurosci.\u00a0https:\/\/doi.org\/10.3389\/fnins.2023.1131758","DOI":"10.3389\/fnins.2023.1131758"},{"key":"8419_CR198","doi-asserted-by":"publisher","unstructured":"Magen I, Yacovzada NS, Yanowski E et al (2021) Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nat Neurosci 24:1534\u20131541. https:\/\/doi.org\/10.1038\/s41593-021-00936-z","DOI":"10.1038\/s41593-021-00936-z"},{"key":"8419_CR199","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00310","volume":"9","author":"B De Felice","year":"2018","unstructured":"De Felice B, Manfellotto F, Fiorentino G et al (2018) Wide-ranging analysis of MicroRNA profiles in sporadic amyotrophic lateral sclerosis using next-generation sequencing. Front Genet 9:310. https:\/\/doi.org\/10.3389\/fgene.2018.00310","journal-title":"Front Genet"},{"key":"8419_CR200","doi-asserted-by":"publisher","unstructured":"Chen Y, Wei Q, Chen X et al (2016) Aberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 9:69. https:\/\/doi.org\/10.3389\/fnmol.2016.00069","DOI":"10.3389\/fnmol.2016.00069"},{"key":"8419_CR201","doi-asserted-by":"publisher","first-page":"728","DOI":"10.4103\/1673-5374.322431","volume":"17","author":"B Martinez","year":"2022","unstructured":"Martinez B, Peplow PV (2022) Microrna expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches. Neural Regen Res 17:728. https:\/\/doi.org\/10.4103\/1673-5374.322431","journal-title":"Neural Regen Res"},{"key":"8419_CR202","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","volume":"5","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Kroh E, Wood B et al (2012) Blood cell origin of circulating micrornas: a cautionary note for cancer biomarker studies. Cancer Prev Res 5:492\u2013497. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-11-0370","journal-title":"Cancer Prev Res"},{"key":"8419_CR203","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41374-018-0143-3","volume":"99","author":"VP Dave","year":"2019","unstructured":"Dave VP, Ngo TA, Pernestig A-K et al (2019) Microrna amplification and detection technologies: opportunities and challenges for point of care diagnostics. Lab Invest 99:452\u2013469. https:\/\/doi.org\/10.1038\/s41374-018-0143-3","journal-title":"Lab Invest"},{"key":"8419_CR204","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/ijc.27799","volume":"132","author":"K Cuk","year":"2013","unstructured":"Cuk K, Zucknick M, Heil J et al (2013) Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 132:1602\u20131612. https:\/\/doi.org\/10.1002\/ijc.27799","journal-title":"Int J Cancer"},{"key":"8419_CR205","doi-asserted-by":"publisher","first-page":"e18388","DOI":"10.1371\/journal.pone.0018388","volume":"6","author":"H Mizuno","year":"2011","unstructured":"Mizuno H, Nakamura A, Aoki Y et al (2011) Identification of muscle-specific MicroRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One 6:e18388. https:\/\/doi.org\/10.1371\/journal.pone.0018388","journal-title":"PLoS One"},{"issue":"1","key":"8419_CR206","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000356447","volume":"1","author":"SK Natarajan","year":"2013","unstructured":"Natarajan SK, Smith MA, Wehrkamp CJ et al (2013) Microrna function in human diseases. Medical Epigenetics 1(1):106\u2013115. https:\/\/doi.org\/10.1159\/000356447","journal-title":"Medical Epigenetics"},{"key":"8419_CR207","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/cells7110219","volume":"7","author":"C Ricci","year":"2018","unstructured":"Ricci C, Marzocchi C, Battistini S (2018) Micrornas as biomarkers in amyotrophic lateral sclerosis. Cells 7:219. https:\/\/doi.org\/10.3390\/cells7110219","journal-title":"Cells"},{"key":"8419_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2020.104060","volume":"127","author":"F Shaker","year":"2020","unstructured":"Shaker F, Nikravesh A, Arezumand R, Aghaee-Bakhtiari SH (2020) Web-based tools for MiRNA studies analysis. Comput Biol Med 127:104060. https:\/\/doi.org\/10.1016\/j.compbiomed.2020.104060","journal-title":"Comput Biol Med"},{"key":"8419_CR209","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17121987","volume":"17","author":"\u00c1L Riffo-Campos","year":"2016","unstructured":"Riffo-Campos \u00c1L, Riquelme I, Brebi-Mieville P (2016) Tools for sequence-based miRNA target prediction: what to choose?? Int J Mol Sci 17:1987. https:\/\/doi.org\/10.3390\/ijms17121987","journal-title":"Int J Mol Sci"},{"key":"8419_CR210","doi-asserted-by":"publisher","first-page":"9101","DOI":"10.1039\/C4AY01602E","volume":"6","author":"Q Ge","year":"2014","unstructured":"Ge Q, Tian F, Zhou Y et al (2014) A universal linker-RT PCR based quantitative method for the detection of circulating miRNAs. Anal Methods 6:9101\u20139107. https:\/\/doi.org\/10.1039\/C4AY01602E","journal-title":"Anal Methods"},{"key":"8419_CR211","doi-asserted-by":"publisher","first-page":"e46890","DOI":"10.1371\/journal.pone.0046890","volume":"7","author":"Q Mei","year":"2012","unstructured":"Mei Q, Li X, Meng Y et al (2012) A facile and specific assay for quantifying MicroRNA by an optimized RT-qPCR approach. PLoS One 7:e46890. https:\/\/doi.org\/10.1371\/journal.pone.0046890","journal-title":"PLoS One"},{"key":"8419_CR212","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2144\/000112010","volume":"39","author":"R Shi","year":"2005","unstructured":"Shi R, Chiang VL (2005) Facile means for quantifying MicroRNA expression by real-time PCR. Biotechniques 39:519\u2013525. https:\/\/doi.org\/10.2144\/000112010","journal-title":"Biotechniques"},{"key":"8419_CR213","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/bfgp\/elp013","volume":"8","author":"PJ Hurd","year":"2009","unstructured":"Hurd PJ, Nelson CJ (2009) Advantages of next-generation sequencing versus the microarray in epigenetic research. Brief Funct Genomics 8:174\u2013183. https:\/\/doi.org\/10.1093\/bfgp\/elp013","journal-title":"Brief Funct Genomics"},{"key":"8419_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2020.100131","volume":"3","author":"P Potla","year":"2021","unstructured":"Potla P, Ali SA, Kapoor M (2021) A bioinformatics approach to microrna-sequencing analysis. Osteoarthritis Cartilage Open 3:100131. https:\/\/doi.org\/10.1016\/j.ocarto.2020.100131","journal-title":"Osteoarthritis Cartilage Open"},{"key":"8419_CR215","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00216-008-2570-2","volume":"394","author":"W Li","year":"2009","unstructured":"Li W, Ruan K (2009) MicroRNA detection by microarray. Anal Bioanal Chem 394:1117\u20131124. https:\/\/doi.org\/10.1007\/s00216-008-2570-2","journal-title":"Anal Bioanal Chem"},{"key":"8419_CR216","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jpha.2019.05.004","volume":"9","author":"J Ye","year":"2019","unstructured":"Ye J, Xu M, Tian X et al (2019) Research advances in the detection of MiRNA. J Pharm Anal 9:217\u2013226. https:\/\/doi.org\/10.1016\/j.jpha.2019.05.004","journal-title":"J Pharm Anal"},{"key":"8419_CR217","doi-asserted-by":"publisher","unstructured":"Pena JT, Sohn-Lee C, Rouhanifard SH, et al (2009) miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat Methods 6:139\u201341. https:\/\/doi.org\/10.1038\/nmeth.1294","DOI":"10.1038\/nmeth.1294"},{"key":"8419_CR218","doi-asserted-by":"publisher","first-page":"013","DOI":"10.4172\/2157-7099.S3-013","volume":"3","author":"D Zhang","year":"2015","unstructured":"Zhang D, Xie L, Jin Y (2015) In situ detection of micrornas: the Art of MicroRNA research in human diseases. J Cytol Histol Suppl 3:013. https:\/\/doi.org\/10.4172\/2157-7099.S3-013","journal-title":"J Cytol Histol Suppl"},{"key":"8419_CR219","doi-asserted-by":"publisher","unstructured":"V\u00e1l\u00f3czi A, Hornyik C, Varga N et al (2004) Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res 32:e175. https:\/\/doi.org\/10.1093\/nar\/gnh171","DOI":"10.1093\/nar\/gnh171"},{"key":"8419_CR220","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1021\/ac4038043","volume":"86","author":"C Shi","year":"2014","unstructured":"Shi C, Liu Q, Ma C, Zhong W (2014) Exponential strand-displacement amplification for detection of microRNAs. Anal Chem 86:336\u2013339. https:\/\/doi.org\/10.1021\/ac4038043","journal-title":"Anal Chem"},{"key":"8419_CR221","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bios.2018.12.041","volume":"128","author":"W Tian","year":"2019","unstructured":"Tian W, Li P, He W et al (2019) Rolling circle extension-actuated loop-mediated isothermal amplification (RCA-LAMP) for ultrasensitive detection of MicroRNAs. Biosens Bioelectron 128:17\u201322. https:\/\/doi.org\/10.1016\/j.bios.2018.12.041","journal-title":"Biosens Bioelectron"},{"key":"8419_CR222","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcmm.12236","volume":"18","author":"L Moldovan","year":"2014","unstructured":"Moldovan L, Batte KE, Trgovcich J et al (2014) Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18:371\u2013390. https:\/\/doi.org\/10.1111\/jcmm.12236","journal-title":"J Cell Mol Med"},{"key":"8419_CR223","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.csbj.2019.06.018","volume":"17","author":"C Zhu","year":"2019","unstructured":"Zhu C, Zhu L, Tan D et al (2019) Avenues toward microRNA detection in vitro: a review of technical advances and challenges. Comput Struct Biotechnol J 17:904\u2013916. https:\/\/doi.org\/10.1016\/j.csbj.2019.06.018","journal-title":"Comput Struct Biotechnol J"},{"key":"8419_CR224","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1039\/c9an01013k","volume":"144","author":"J Huang","year":"2019","unstructured":"Huang J, Shangguan J, Guo Q et al (2019) Colorimetric and fluorescent dual-mode detection of MicroRNA based on duplex-specific nuclease assisted gold nanoparticle amplification. Analyst 144:4917\u20134924. https:\/\/doi.org\/10.1039\/c9an01013k","journal-title":"Analyst"},{"key":"8419_CR225","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/acssensors.2c00149","volume":"7","author":"CSM Martins","year":"2022","unstructured":"Martins CSM, LaGrow AP, Prior JAV (2022) Quantum dots for cancer-related miRNA monitoring. ACS Sens 7:1269\u20131299. https:\/\/doi.org\/10.1021\/acssensors.2c00149","journal-title":"ACS Sens"},{"key":"8419_CR226","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.1021\/acs.analchem.8b01111","volume":"90","author":"J Dong","year":"2018","unstructured":"Dong J, Chen G, Wang W et al (2018) Colorimetric PCR-based microRNA detection method based on small organic dye and single enzyme. Anal Chem 90:7107\u20137111. https:\/\/doi.org\/10.1021\/acs.analchem.8b01111","journal-title":"Anal Chem"},{"key":"8419_CR227","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7150\/thno.28474","volume":"9","author":"W Peng","year":"2019","unstructured":"Peng W, Zhao Q, Chen M et al (2019) An innovative unlocked mechanism by a double key avenue for one-pot detection of microRNA-21 and microRNA-141. Theranostics 9:279\u2013289. https:\/\/doi.org\/10.7150\/thno.28474","journal-title":"Theranostics"},{"key":"8419_CR228","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1021\/ac403944c","volume":"86","author":"Q Xi","year":"2014","unstructured":"Xi Q, Zhou D-M, Kan Y-Y et al (2014) Highly sensitive and selective strategy for microRNA detection based on WS2 nanosheet mediated fluorescence quenching and duplex-specific nuclease signal amplification. Anal Chem 86:1361\u20131365. https:\/\/doi.org\/10.1021\/ac403944c","journal-title":"Anal Chem"},{"key":"8419_CR229","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1002\/anie.201001375","volume":"49","author":"H Jia","year":"2010","unstructured":"Jia H, Li Z, Liu C, Cheng Y (2010) Ultrasensitive detection of MicroRNAs by exponential isothermal amplification. Angew Chem Int Ed 49:5498\u20135501. https:\/\/doi.org\/10.1002\/anie.201001375","journal-title":"Angew Chem Int Ed"},{"key":"8419_CR230","doi-asserted-by":"publisher","first-page":"12451","DOI":"10.1039\/C9CC05607F","volume":"55","author":"S Pavagada","year":"2019","unstructured":"Pavagada S, Channon RB, Chang JYH et al (2019) Oligonucleotide-templated lateral flow assays for amplification-free sensing of circulating MicroRNAs. Chem Commun 55:12451\u201312454. https:\/\/doi.org\/10.1039\/C9CC05607F","journal-title":"Chem Commun"},{"key":"8419_CR231","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/bios12121172","volume":"12","author":"G Ashraf","year":"2022","unstructured":"Ashraf G, Zhong Z-T, Asif M et al (2022) State-of-the-art fluorescent probes: duplex-specific nuclease-based strategies for early disease diagnostics. Biosensors 12:1172. https:\/\/doi.org\/10.3390\/bios12121172","journal-title":"Biosensors"},{"key":"8419_CR232","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1002\/anie.200805665","volume":"48","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Zhang X, Li Z et al (2009) Highly sensitive determination of MicroRNA using target-primed and branched rolling-circle amplification. Angew Chem Int Ed 48:3268\u20133272. https:\/\/doi.org\/10.1002\/anie.200805665","journal-title":"Angew Chem Int Ed"},{"key":"8419_CR233","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/acsomega.1c05775","volume":"7","author":"K Djebbi","year":"2022","unstructured":"Djebbi K, Shi B, Weng T et al (2022) Highly sensitive fluorescence assay for miRNA detection: investigation of the DNA spacer effect on the DSN enzyme activity toward magnetic-bead-tethered probes. ACS Omega 7:2224\u20132233. https:\/\/doi.org\/10.1021\/acsomega.1c05775","journal-title":"ACS Omega"},{"key":"8419_CR234","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.bios.2015.12.052","volume":"79","author":"Y Pang","year":"2016","unstructured":"Pang Y, Wang C, Wang J et al (2016) Fe3O4@Ag magnetic nanoparticles for microRNA capture and duplex-specific nuclease signal amplification based SERS detection in cancer cells. Biosens Bioelectron 79:574\u2013580. https:\/\/doi.org\/10.1016\/j.bios.2015.12.052","journal-title":"Biosens Bioelectron"},{"key":"8419_CR235","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/bios10110186","volume":"10","author":"M El Aamri","year":"2020","unstructured":"El Aamri M, Yammouri G, Mohammadi H et al (2020) Electrochemical biosensors for detection of MicroRNA as a cancer biomarker: pros and cons. Biosensors 10:186. https:\/\/doi.org\/10.3390\/bios10110186","journal-title":"Biosensors"},{"key":"8419_CR236","doi-asserted-by":"publisher","DOI":"10.1039\/D5TB00472A","author":"A Taghavi-Kahagh","year":"2025","unstructured":"Taghavi-Kahagh A, Behboodi-Sadabad F, Salami-Kalajahi M (2025) miRNAs electrochemical biosensors based on MXene and MBene nanomaterials: recent advances and future perspectives. J Mater Chem B. https:\/\/doi.org\/10.1039\/D5TB00472A","journal-title":"J Mater Chem B"},{"key":"8419_CR237","doi-asserted-by":"publisher","first-page":"e48329","DOI":"10.1371\/journal.pone.0048329","volume":"7","author":"H Arata","year":"2012","unstructured":"Arata H, Komatsu H, Hosokawa K, Maeda M (2012) Rapid and sensitive microrna detection with laminar flow-assisted dendritic amplification on power-free microfluidic chip. PLoS One 7:e48329. https:\/\/doi.org\/10.1371\/journal.pone.0048329","journal-title":"PLoS One"},{"key":"8419_CR238","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13036-022-00312-w","volume":"16","author":"D Gao","year":"2022","unstructured":"Gao D, Guo X, Yang Y et al (2022) Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acid. J Biol Eng 16:33. https:\/\/doi.org\/10.1186\/s13036-022-00312-w","journal-title":"J Biol Eng"},{"key":"8419_CR239","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.585","volume":"12","author":"D de Gonzalo-Calvo","year":"2022","unstructured":"de Gonzalo-Calvo D, P\u00e9rez\u2010Boza J, Curado J, Devaux Y (2022) Challenges of microRNA\u2010based biomarkers in clinical application for cardiovascular diseases. Clin Transl Med 12:e585. https:\/\/doi.org\/10.1002\/ctm2.585","journal-title":"Clin Transl Med"},{"key":"8419_CR240","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.1021\/acs.analchem.6b01225","volume":"88","author":"H Tian","year":"2016","unstructured":"Tian H, Sun Y, Liu C et al (2016) Precise quantitation of microRNA in a single cell with droplet digital PCR based on ligation reaction. Anal Chem 88:11384\u201311389. https:\/\/doi.org\/10.1021\/acs.analchem.6b01225","journal-title":"Anal Chem"},{"key":"8419_CR241","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/joim.12921","volume":"286","author":"D de Gonzalo-Calvo","year":"2019","unstructured":"de Gonzalo-Calvo D, Vilades D, Mart\u00ednez-Camblor P et al (2019) Circulating microRNAs in suspected stable coronary artery disease: a coronary computed tomography angiography study. J Intern Med 286:341\u2013355. https:\/\/doi.org\/10.1111\/joim.12921","journal-title":"J Intern Med"},{"key":"8419_CR242","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jacc.2018.11.060","volume":"73","author":"LL Wong","year":"2019","unstructured":"Wong LL, Zou R, Zhou L et al (2019) Combining circulating microrna and NT-proBNP to detect and categorize heart failure subtypes. J Am Coll Cardiol 73:1300\u20131313. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.060","journal-title":"J Am Coll Cardiol"},{"key":"8419_CR243","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12864-019-5826-7","volume":"20","author":"RKY Wong","year":"2019","unstructured":"Wong RKY, MacMahon M, Woodside JV, Simpson DA (2019) A comparison of RNA extraction and sequencing protocols for detection of small RNAs in plasma. BMC Genomics 20:446. https:\/\/doi.org\/10.1186\/s12864-019-5826-7","journal-title":"BMC Genomics"},{"key":"8419_CR244","doi-asserted-by":"publisher","first-page":"1713540","DOI":"10.1080\/20013078.2020.1713540","volume":"9","author":"MYS Kalani","year":"2020","unstructured":"Kalani MYS, Alsop E, Meechoovet B et al (2020) Extracellular MicroRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes. J Extracell Vesicles 9:1713540. https:\/\/doi.org\/10.1080\/20013078.2020.1713540","journal-title":"J Extracell Vesicles"},{"key":"8419_CR245","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26114975","volume":"26","author":"SA Bustin","year":"2025","unstructured":"Bustin SA (2025) MIQE 2.0 and the urgent need to rethink qPCR standards. Int J Mol Sci 26:4975. https:\/\/doi.org\/10.3390\/ijms26114975","journal-title":"Int J Mol Sci"},{"key":"8419_CR246","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1515\/cclm-2024-0531","volume":"62","author":"M Sopi\u0107","year":"2024","unstructured":"Sopi\u0107 M, Devaux Y, de Gonzalo-Calvo D (2024) Navigating the path of reproducibility in microRNA-based biomarker research with ring trials. Clin Chem Lab Med 62:2393\u20132397. https:\/\/doi.org\/10.1515\/cclm-2024-0531","journal-title":"Clin Chem Lab Med"},{"key":"8419_CR247","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1021\/cr300362f","volume":"113","author":"H Dong","year":"2013","unstructured":"Dong H, Lei J, Ding L et al (2013) MicroRNA: function, detection, and bioanalysis. Chem Rev 113:6207\u20136233. https:\/\/doi.org\/10.1021\/cr300362f","journal-title":"Chem Rev"},{"issue":"8","key":"8419_CR248","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1101\/gad.1074403","volume":"17","author":"LP Lim","year":"2003","unstructured":"Lim LP, Lau NC, Weinstein EG et al (2003) The microRNAs of caenorhabditis elegans. Genes Dev 17(8):991\u20131008. https:\/\/doi.org\/10.1101\/gad.1074403","journal-title":"Genes Dev"},{"key":"8419_CR249","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/diagnostics11060964","volume":"11","author":"S Benesova","year":"2021","unstructured":"Benesova S, Kubista M, Valihrach L (2021) Small RNA-sequencing: approaches and considerations for miRNA analysis. Diagnostics 11:964. https:\/\/doi.org\/10.3390\/diagnostics11060964","journal-title":"Diagnostics"},{"key":"8419_CR250","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.7150\/thno.46123","volume":"10","author":"D de Gonzalo-Calvo","year":"2020","unstructured":"de Gonzalo-Calvo D, Mart\u00ednez-Camblor P, B\u00e4r C et al (2020) Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids. Theranostics 10:8665\u20138676. https:\/\/doi.org\/10.7150\/thno.46123","journal-title":"Theranostics"},{"key":"8419_CR251","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/iju.iju_442_24","volume":"41","author":"R Tripathy","year":"2025","unstructured":"Tripathy R, Kumar L, Kural S et al (2025) The current status of MiRNA in urinary bladder cancer: a minireview and strength, weakness, opportunity, and threat analysis. Indian J Urol 41:98. https:\/\/doi.org\/10.4103\/iju.iju_442_24","journal-title":"Indian J Urol"},{"key":"8419_CR252","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.915226","author":"D Sur","year":"2022","unstructured":"Sur D, Advani S, Braithwaite D (2022) Microrna panels as diagnostic biomarkers for colorectal cancer: a systematic review and meta-analysis. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.915226","journal-title":"Front Med"},{"key":"8419_CR253","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/cells12070983","volume":"12","author":"PB Udesen","year":"2023","unstructured":"Udesen PB, S\u00f8rensen AE, Svendsen R et al (2023) Circulating miRNAs in women with polycystic ovary syndrome: a longitudinal cohort study. Cells 12:983. https:\/\/doi.org\/10.3390\/cells12070983","journal-title":"Cells"},{"key":"8419_CR254","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","volume":"44","author":"MTD Martino","year":"2025","unstructured":"Martino MTD, Tagliaferri P, Tassone P (2025) Microrna in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res 44:126. https:\/\/doi.org\/10.1186\/s13046-025-03391-x","journal-title":"J Exp Clin Cancer Res"},{"key":"8419_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102373","volume":"35","author":"P Shirmast","year":"2024","unstructured":"Shirmast P, Shahri MA, Brent A et al (2024) Delivering therapeutic RNA into the brain using extracellular vesicles. Mol Ther 35:102373. https:\/\/doi.org\/10.1016\/j.omtn.2024.102373","journal-title":"Mol Ther"},{"key":"8419_CR256","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD (2024) Micrornas: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene 43:2135\u20132142. https:\/\/doi.org\/10.1038\/s41388-024-03076-3","journal-title":"Oncogene"},{"key":"8419_CR257","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1002\/1878-0261.13026","volume":"15","author":"N Laprovitera","year":"2021","unstructured":"Laprovitera N, Riefolo M, Porcellini E et al (2021) Microrna expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary. Mol Oncol 15:2732\u20132751. https:\/\/doi.org\/10.1002\/1878-0261.13026","journal-title":"Mol Oncol"},{"key":"8419_CR258","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-7046-9_4","volume":"1617","author":"W Huang","year":"2017","unstructured":"Huang W (2017) Micrornas: biomarkers, diagnostics, and therapeutics. Methods Mol Biol Clifton NJ 1617:57\u201367. https:\/\/doi.org\/10.1007\/978-1-4939-7046-9_4","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"8419_CR259","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2021.030705","volume":"31","author":"H Sriram","year":"2021","unstructured":"Sriram H, Khanka T, Kedia S et al (2021) Improved protocol for plasma microRNA extraction and comparison of commercial kits. Biochem Med 31:030705. https:\/\/doi.org\/10.11613\/BM.2021.030705","journal-title":"Biochem Med"},{"key":"8419_CR260","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jaac.2019.03.017","volume":"59","author":"SD Hicks","year":"2020","unstructured":"Hicks SD, Carpenter RL, Wagner KE et al (2020) Saliva microRNA differentiates children with autism from peers with typical and atypical development. J Am Acad Child Adolesc Psychiatry 59:296\u2013308. https:\/\/doi.org\/10.1016\/j.jaac.2019.03.017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8419_CR261","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","volume":"231","author":"J Wang","year":"2016","unstructured":"Wang J, Chen J, Sen S (2016) Microrna as biomarkers and diagnostics. J Cell Physiol 231:25\u201330. https:\/\/doi.org\/10.1002\/jcp.25056","journal-title":"J Cell Physiol"},{"key":"8419_CR262","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41587-024-02480-0","volume":"42","author":"Nature Biotechnology","year":"2024","unstructured":"Biotechnology Nature (2024) What will it take to get miRNA therapies to market? Nat Biotechnol 42:1623\u20131624. https:\/\/doi.org\/10.1038\/s41587-024-02480-0","journal-title":"Nat Biotechnol"},{"key":"8419_CR263","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-023-01957-7","volume":"22","author":"M Samadishadlou","year":"2023","unstructured":"Samadishadlou M, Rahbarghazi R, Piryaei Z et al (2023) Unlocking the potential of micrornas: machine learning identifies key biomarkers for myocardial infarction diagnosis. Cardiovasc Diabetol 22:247. https:\/\/doi.org\/10.1186\/s12933-023-01957-7","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"8419_CR264","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/2229-3485.179431","volume":"7","author":"AF Christopher","year":"2016","unstructured":"Christopher AF, Kaur RP, Kaur G et al (2016) Microrna therapeutics: discovering novel targets and developing specific therapy. Perspect Clin Res 7:68. https:\/\/doi.org\/10.4103\/2229-3485.179431","journal-title":"Perspect Clin Res"},{"key":"8419_CR265","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1242\/dmm.028613","volume":"10","author":"EY Liu","year":"2017","unstructured":"Liu EY, Cali CP, Lee EB (2017) RNA metabolism in neurodegenerative disease. Dis Model Mech 10:509\u2013518. https:\/\/doi.org\/10.1242\/dmm.028613","journal-title":"Dis Model Mech"},{"key":"8419_CR266","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41544-019-0024-y","volume":"1","author":"Y Fu","year":"2019","unstructured":"Fu Y, Chen J, Huang Z (2019) Recent progress in microRNA-based delivery systems for the treatment of human disease. ExRNA 1:24. https:\/\/doi.org\/10.1186\/s41544-019-0024-y","journal-title":"ExRNA"},{"key":"8419_CR267","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.4155\/fmc.15.107","volume":"7","author":"BC Bernardo","year":"2015","unstructured":"Bernardo BC, Ooi JY, Lin RC, McMullen JR (2015) miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem 7:1771\u20131792. https:\/\/doi.org\/10.4155\/fmc.15.107","journal-title":"Future Med Chem"},{"key":"8419_CR268","doi-asserted-by":"publisher","unstructured":"Sun P, Liu DZ, Jickling GC et al (2018) MicroRNA-based therapeutics in central nervous system injuries. J Cereb Blood Flow Metab 38:1125\u20131148. https:\/\/doi.org\/10.1177\/0271678X18773871","DOI":"10.1177\/0271678X18773871"},{"key":"8419_CR269","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/cells9010137","volume":"9","author":"S Bajan","year":"2020","unstructured":"Bajan S, Hutvagner G (2020) RNA-based therapeutics: from antisense oligonucleotides to miRNAs. Cells 9:137. https:\/\/doi.org\/10.3390\/cells9010137","journal-title":"Cells"},{"key":"8419_CR270","doi-asserted-by":"publisher","unstructured":"Leclercq M, Diallo AB, Blanchette M (2017) Prediction of human miRNA target genes using computationally reconstructed ancestral mammalian sequences. Nucleic Acids Res 45:556\u2013566. https:\/\/doi.org\/10.1093\/nar\/gkw1085","DOI":"10.1093\/nar\/gkw1085"},{"key":"8419_CR271","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1261\/rna.054072.115","volume":"22","author":"MA Goldgraben","year":"2016","unstructured":"Goldgraben MA, Russell R, Rueda OM et al (2016) Double-stranded microRNA mimics can induce length- and passenger strand\u2013dependent effects in a cell type\u2013specific manner. RNA 22:193\u2013203. https:\/\/doi.org\/10.1261\/rna.054072.115","journal-title":"RNA"},{"key":"8419_CR272","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1038\/s41598-018-26050-y","volume":"8","author":"H-M Lin","year":"2018","unstructured":"Lin H-M, Nikolic I, Yang J et al (2018) MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer. Sci Rep 8:7820. https:\/\/doi.org\/10.1038\/s41598-018-26050-y","journal-title":"Sci Rep"},{"key":"8419_CR273","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2017.05.025","volume":"407","author":"L Tang","year":"2017","unstructured":"Tang L, Chen H-Y, Hao N-B et al (2017) microRNA inhibitors: Natural and artificial sequestration of microRNA. Cancer Lett 407:139\u2013147. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.025","journal-title":"Cancer Lett"},{"key":"8419_CR274","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20:460\u2013469. https:\/\/doi.org\/10.1016\/j.molmed.2014.06.005","journal-title":"Trends Mol Med"},{"key":"8419_CR275","doi-asserted-by":"publisher","unstructured":"Campbell K, Booth SA (2015) MicroRNA in neurodegenerative drug discovery: the way forward? Expert Opin Drug Discov 10:9\u201316. https:\/\/doi.org\/10.1517\/17460441.2015.981254","DOI":"10.1517\/17460441.2015.981254"},{"key":"8419_CR276","doi-asserted-by":"publisher","unstructured":"Wang Z (2009) miRNA Mimic Technology. In: Wang Z (ed) MicroRNA interference technologies. Springer, Berlin, Heidelberg, pp 93\u2013100.\u00a0https:\/\/doi.org\/10.1007\/978-3-642-00489-6_4","DOI":"10.1007\/978-3-642-00489-6_4"},{"key":"8419_CR277","doi-asserted-by":"publisher","unstructured":"Boutla A, Delidakis C, Tabler M (2003) Developmental defects by antisense\u2010mediated inactivation of micro\u2010RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res 31:4973\u20134980. https:\/\/doi.org\/10.1093\/nar\/gkg707","DOI":"10.1093\/nar\/gkg707"},{"key":"8419_CR278","doi-asserted-by":"publisher","unstructured":"Vester B, Wengel J (2004) LNA (Locked Nucleic Acid): High-affinity targeting of complementary RNA and DNA. Biochemistry 43:13233\u201313241. https:\/\/doi.org\/10.1021\/bi0485732","DOI":"10.1021\/bi0485732"},{"key":"8419_CR279","doi-asserted-by":"publisher","unstructured":"Wang Z (2009) miRNA-masking antisense oligonucleotides technology. In: Wang Z (ed) MicroRNA interference technologies. Springer, Berlin, Heidelberg, pp 161\u2013166.\u00a0https:\/\/doi.org\/10.1007\/978-3-642-00489-6_10","DOI":"10.1007\/978-3-642-00489-6_10"},{"key":"8419_CR280","doi-asserted-by":"publisher","unstructured":"Hansen TB, Jensen TI, Clausen BH et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495:384\u2013388. https:\/\/doi.org\/10.1038\/nature11993","DOI":"10.1038\/nature11993"},{"key":"8419_CR281","doi-asserted-by":"publisher","unstructured":"Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721\u2013726. https:\/\/doi.org\/10.1038\/nmeth1079","DOI":"10.1038\/nmeth1079"},{"key":"8419_CR282","doi-asserted-by":"publisher","unstructured":"Bak RO, Mikkelsen JG (2014) miRNA sponges: soaking up miRNAs for regulation of gene expression. WIREs RNA 5:317\u2013333. https:\/\/doi.org\/10.1002\/wrna.1213","DOI":"10.1002\/wrna.1213"},{"key":"8419_CR283","doi-asserted-by":"publisher","unstructured":"Misir S, Hepokur C, Aliyazicioglu Y, Enguita FJ (2020) Circular RNAs serve as miRNA sponges in breast cancer. Breast Cancer 27:1048\u20131057. https:\/\/doi.org\/10.1007\/s12282-020-01140-w","DOI":"10.1007\/s12282-020-01140-w"},{"key":"8419_CR284","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00018-015-2093-x","volume":"73","author":"I Basak","year":"2016","unstructured":"Basak I, Patil KS, Alves G et al (2016) microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases. Cell Mol Life Sci 73:811\u2013827. https:\/\/doi.org\/10.1007\/s00018-015-2093-x","journal-title":"Cell Mol Life Sci"},{"key":"8419_CR285","doi-asserted-by":"publisher","unstructured":"Shan G, Li Y, Zhang J, et al (2008) A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol 26:933\u2013940. https:\/\/doi.org\/10.1038\/nbt.1481","DOI":"10.1038\/nbt.1481"},{"key":"8419_CR286","doi-asserted-by":"publisher","unstructured":"Van Meter EN, Onyango JA, Teske KA (2020) A review of currently identified small molecule modulators of microRNA function. Eur J Med Chem 188:112008. https:\/\/doi.org\/10.1016\/j.ejmech.2019.112008","DOI":"10.1016\/j.ejmech.2019.112008"},{"key":"8419_CR287","doi-asserted-by":"publisher","unstructured":"Yoo BH, Bochkareva E, Bochkarev A et al (2004) 2\u2032-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro. Nucleic Acids Res 32:2008\u20132016. https:\/\/doi.org\/10.1093\/nar\/gkh516","DOI":"10.1093\/nar\/gkh516"},{"key":"8419_CR288","doi-asserted-by":"publisher","unstructured":"Saenz-Pipaon G, Dichek DA (2023) Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases. Atherosclerosis 374:44\u201354. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.12.003","DOI":"10.1016\/j.atherosclerosis.2022.12.003"},{"key":"8419_CR289","doi-asserted-by":"publisher","unstructured":"Kr\u00fctzfeldt J, Rajewsky N, Braich R, et al (2005) Silencing of microRNAs in vivo with antagomirs. Nature 438:685\u2013689. https:\/\/doi.org\/10.1038\/nature04303","DOI":"10.1038\/nature04303"},{"key":"8419_CR290","doi-asserted-by":"publisher","unstructured":"Seyhan AA (2024) Trials and tribulations of microRNA therapeutics. Int J Mol Sci 25:1469. https:\/\/doi.org\/10.3390\/ijms25031469","DOI":"10.3390\/ijms25031469"},{"key":"8419_CR291","doi-asserted-by":"publisher","unstructured":"Lee SWL, Paoletti C, Campisi M et al (2019) Microrna delivery through nanoparticles. J Controlled Release 313:80\u201395. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.007","DOI":"10.1016\/j.jconrel.2019.10.007"},{"key":"8419_CR292","doi-asserted-by":"publisher","unstructured":"Mijanovi\u0107 O, Brankovi\u0107 A, Borovjagin AV et al (2020) Battling neurodegenerative diseases with adeno-associated virus-based approaches. Viruses 12:460. https:\/\/doi.org\/10.3390\/v12040460","DOI":"10.3390\/v12040460"},{"key":"8419_CR293","doi-asserted-by":"publisher","unstructured":"Ling H, Fabbri M, Calin GA (2013) MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12:847\u2013865. https:\/\/doi.org\/10.1038\/nrd4140","DOI":"10.1038\/nrd4140"},{"key":"8419_CR294","unstructured":"Dias N, Stein CA (2002) Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther 1:347\u2013355"},{"key":"8419_CR295","doi-asserted-by":"publisher","unstructured":"Choi W-Y, Giraldez AJ, Schier AF (2007) Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430. Science 318:271\u2013274. https:\/\/doi.org\/10.1126\/science.1147535","DOI":"10.1126\/science.1147535"},{"key":"8419_CR296","doi-asserted-by":"publisher","unstructured":"Paul S, Bravo V\u00e1zquez LA, P\u00e9rez Uribe S, et al (2020) Current status of microRNA-based therapeutic approaches in neurodegenerative disorders. Cells 9:1698. https:\/\/doi.org\/10.3390\/cells9071698","DOI":"10.3390\/cells9071698"},{"key":"8419_CR297","doi-asserted-by":"publisher","unstructured":"Gumireddy K, Young DD, Xiong X, et al (2008) Small-molecule Inhibitors of microRNA miR-21 function. Angew Chem 120:7592\u20137594. https:\/\/doi.org\/10.1002\/ange.200801555","DOI":"10.1002\/ange.200801555"},{"key":"8419_CR298","doi-asserted-by":"publisher","unstructured":"Lujambio A, Ropero S, Ballestar E, et al (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67:1424\u20131429. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4218","DOI":"10.1158\/0008-5472.CAN-06-4218"},{"key":"8419_CR299","doi-asserted-by":"publisher","unstructured":"Melo S, Villanueva A, Moutinho C, et al (2011) Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci 108:4394\u20134399. https:\/\/doi.org\/10.1073\/pnas.1014720108","DOI":"10.1073\/pnas.1014720108"},{"key":"8419_CR300","doi-asserted-by":"publisher","unstructured":"Shah MY, Calin GA (2014) Micrornas as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA 5:537\u2013548. https:\/\/doi.org\/10.1002\/wrna.1229","DOI":"10.1002\/wrna.1229"},{"key":"8419_CR301","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/1389557515666150324123208","volume":"15","author":"B Simonson","year":"2015","unstructured":"Simonson B, Das S (2015) MicroRNA therapeutics: the next magic bullet?? Mini-Rev Med Chem 15:467\u2013474","journal-title":"Mini-Rev Med Chem"},{"key":"8419_CR302","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.drudis.2012.10.002","volume":"18","author":"DM Pereira","year":"2013","unstructured":"Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CMP (2013) Delivering the promise of MiRNA cancer therapeutics. Drug Discov Today 18:282\u2013289. https:\/\/doi.org\/10.1016\/j.drudis.2012.10.002","journal-title":"Drug Discov Today"},{"key":"8419_CR303","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.33","volume":"4","author":"S Parsi","year":"2015","unstructured":"Parsi S, Smith PY, Goupil C et al (2015) Preclinical evaluation of miR-15\/107 family members as multifactorial drug targets for alzheimer\u2019s disease. Mol Ther 4:e256. https:\/\/doi.org\/10.1038\/mtna.2015.33","journal-title":"Mol Ther"},{"key":"8419_CR304","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","volume":"24","author":"PY Smith","year":"2015","unstructured":"Smith PY, Hernandez-Rapp J, Jolivette F et al (2015) MiR-132\/212 deficiency impairs Tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet 24:6721\u20136735. https:\/\/doi.org\/10.1093\/hmg\/ddv377","journal-title":"Hum Mol Genet"},{"key":"8419_CR305","doi-asserted-by":"publisher","unstructured":"Salta E, Sierksma A, Vanden Eynden E, De Strooper B (2016) miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in alzheimer\u2019s brain. EMBO Mol Med 8:1005\u20131018. https:\/\/doi.org\/10.15252\/emmm.201606520","DOI":"10.15252\/emmm.201606520"},{"key":"8419_CR306","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.toxlet.2011.11.032","volume":"209","author":"M Fang","year":"2012","unstructured":"Fang M, Wang J, Zhang X et al (2012) The miR-124 regulates the expression of BACE1\/\u03b2-secretase correlated with cell death in alzheimer\u2019s disease. Toxicol Lett 209:94\u2013105. https:\/\/doi.org\/10.1016\/j.toxlet.2011.11.032","journal-title":"Toxicol Lett"},{"key":"8419_CR307","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110814","volume":"130","author":"F Cao","year":"2020","unstructured":"Cao F, Liu Z, Sun G (2020) Diagnostic value of miR-193a-3p in alzheimer\u2019s disease and miR-193a-3p attenuates amyloid-\u03b2 induced neurotoxicity by targeting PTEN. Exp Gerontol 130:110814. https:\/\/doi.org\/10.1016\/j.exger.2019.110814","journal-title":"Exp Gerontol"},{"key":"8419_CR308","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jcp.28988","volume":"235","author":"B He","year":"2020","unstructured":"He B, Chen W, Zeng J et al (2020) Microrna-326 decreases Tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in alzheimer\u2019s disease. J Cell Physiol 235:480\u2013493. https:\/\/doi.org\/10.1002\/jcp.28988","journal-title":"J Cell Physiol"},{"key":"8419_CR309","doi-asserted-by":"publisher","unstructured":"Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P et al (2011) microRNA-34c is a novel target to treat dementias. EMBO J 30:4299\u20134308. https:\/\/doi.org\/10.1038\/emboj.2011.327","DOI":"10.1038\/emboj.2011.327"},{"key":"8419_CR310","doi-asserted-by":"publisher","DOI":"10.1038\/srep34433","volume":"6","author":"K Lee","year":"2016","unstructured":"Lee K, Kim H, An K et al (2016) Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD mouse model of alzheimer\u2019s disease. Sci Rep 6:34433. https:\/\/doi.org\/10.1038\/srep34433","journal-title":"Sci Rep"},{"key":"8419_CR311","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1007\/s12035-020-01868-8","volume":"57","author":"O Zolochevska","year":"2020","unstructured":"Zolochevska O, Taglialatela G (2020) Selected microRNAs increase synaptic resilience to the damaging binding of the alzheimer\u2019s disease amyloid beta oligomers. Mol Neurobiol 57:2232\u20132243. https:\/\/doi.org\/10.1007\/s12035-020-01868-8","journal-title":"Mol Neurobiol"},{"key":"8419_CR312","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.neurobiolaging.2010.04.034","volume":"33","author":"W Liu","year":"2012","unstructured":"Liu W, Liu C, Zhu J et al (2012) Microrna-16 targets amyloid precursor protein to potentially modulate Alzheimer\u2019s-associated pathogenesis in SAMP8 mice. Neurobiol Aging 33:522\u2013534. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.034","journal-title":"Neurobiol Aging"},{"key":"8419_CR313","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113128","volume":"324","author":"G-D Wu","year":"2020","unstructured":"Wu G-D, Li Z-H, Li X et al (2020) Microrna-592 blockade inhibits oxidative stress injury in alzheimer\u2019s disease astrocytes via the KIAA0319-mediated Keap1\/Nrf2\/ARE signaling pathway. Exp Neurol 324:113128. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113128","journal-title":"Exp Neurol"},{"key":"8419_CR314","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbrc.2010.12.053","volume":"404","author":"JM Long","year":"2011","unstructured":"Long JM, Lahiri DK (2011) Microrna-101 downregulates alzheimer\u2019s amyloid-\u03b2 precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404:889\u2013895. https:\/\/doi.org\/10.1016\/j.bbrc.2010.12.053","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"8419_CR315","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.23588","volume":"72","author":"S-T Lee","year":"2012","unstructured":"Lee S-T, Chu K, Jung K-H et al (2012) Mir-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol 72(2):269\u2013277. https:\/\/doi.org\/10.1002\/ana.23588","journal-title":"Ann Neurol"},{"key":"8419_CR316","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainres.2014.01.010","volume":"1550","author":"CE Khodr","year":"2014","unstructured":"Khodr CE, Becerra A, Han Y, Bohn MC (2014) Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: positive and negative effects. Brain Res 1550:47\u201360. https:\/\/doi.org\/10.1016\/j.brainres.2014.01.010","journal-title":"Brain Res"},{"key":"8419_CR317","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li D, Yang H, Ma J et al (2018) Microrna-30e regulates neuroinflammation in MPTP model of parkinson\u2019s disease by targeting Nlrp3. Hum Cell 31:106\u2013115. https:\/\/doi.org\/10.1007\/s13577-017-0187-5","journal-title":"Hum Cell"},{"key":"8419_CR318","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/bpa.12267","volume":"26","author":"H Wang","year":"2016","unstructured":"Wang H, Ye Y, Zhu Z et al (2016) MiR-124 regulates apoptosis and autophagy process in MPTP model of parkinson\u2019s disease by targeting to Bim. Brain Pathol Zurich Switz 26:167\u2013176. https:\/\/doi.org\/10.1111\/bpa.12267","journal-title":"Brain Pathol Zurich Switz"},{"key":"8419_CR319","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jconrel.2016.06.005","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Paiva J, Santos T et al (2016) Microrna-124 loaded nanoparticles enhance brain repair in parkinson\u2019s disease. J Control Release 235:291\u2013305. https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.005","journal-title":"J Control Release"},{"key":"8419_CR320","doi-asserted-by":"publisher","DOI":"10.1080\/23262133.2016.1256855","volume":"3","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Ferreira L, Bernardino L (2016) Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for parkinson\u2019s disease. Neurogenesis 3:e1256855. https:\/\/doi.org\/10.1080\/23262133.2016.1256855","journal-title":"Neurogenesis"},{"key":"8419_CR321","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.12659\/MSM.900218","volume":"23","author":"Y Liu","year":"2017","unstructured":"Liu Y, Song Y, Zhu X (2017) Microrna-181a regulates apoptosis and autophagy process in parkinson\u2019s disease by inhibiting p38 Mitogen-activated protein kinase (MAPK)\/c-Jun N-terminal kinases (JNK) signaling pathways. Med Sci Monit 23:1597\u20131606. https:\/\/doi.org\/10.12659\/MSM.900218","journal-title":"Med Sci Monit"},{"key":"8419_CR322","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du R-H et al (2016) Microrna-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of parkinson\u2019s disease. Mol Neurodegener 11:28. https:\/\/doi.org\/10.1186\/s13024-016-0094-3","journal-title":"Mol Neurodegener"},{"key":"8419_CR323","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2018.03.037","volume":"675","author":"L Geng","year":"2018","unstructured":"Geng L, Zhang T, Liu W, Chen Y (2018) Mir-494-3p modulates the progression of in vitro and in vivo parkinson\u2019s disease models by targeting SIRT3. Neurosci Lett 675:23\u201330. https:\/\/doi.org\/10.1016\/j.neulet.2018.03.037","journal-title":"Neurosci Lett"},{"key":"8419_CR324","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2019.02.038","volume":"701","author":"Z Wang","year":"2019","unstructured":"Wang Z, Sun L, Jia K et al (2019) MiR-9-5p modulates the progression of parkinson\u2019s disease by targeting SIRT1. Neurosci Lett 701:226\u2013233. https:\/\/doi.org\/10.1016\/j.neulet.2019.02.038","journal-title":"Neurosci Lett"},{"key":"8419_CR325","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s10020-018-0059-9","volume":"24","author":"Y Dong","year":"2018","unstructured":"Dong Y, Han L-L, Xu Z-X (2018) Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with parkinson\u2019s disease. Mol Med 24:61. https:\/\/doi.org\/10.1186\/s10020-018-0059-9","journal-title":"Mol Med"},{"key":"8419_CR326","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11011-020-00546-x","volume":"35","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang M, Wei M et al (2020) Microrna-216a inhibits neuronal apoptosis in a cellular parkinson\u2019s disease model by targeting Bax. Metab Brain Dis 35:627\u2013635. https:\/\/doi.org\/10.1007\/s11011-020-00546-x","journal-title":"Metab Brain Dis"},{"key":"8419_CR327","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.7","volume":"4","author":"AM Monteys","year":"2015","unstructured":"Monteys AM, Wilson MJ, Boudreau RL et al (2015) Artificial miRNAs targeting mutant Huntingtin show preferential silencing in vitro and in vivo. Mol Ther 4:e234. https:\/\/doi.org\/10.1038\/mtna.2015.7","journal-title":"Mol Ther"},{"key":"8419_CR328","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bbrc.2017.05.040","volume":"488","author":"J-J Ban","year":"2017","unstructured":"Ban J-J, Chung J-Y, Lee M et al (2017) Microrna-27a reduces mutant Hutingtin aggregation in an in vitro model of huntington\u2019s disease. Biochem Biophys Res Commun 488:316\u2013321. https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.040","journal-title":"Biochem Biophys Res Commun"},{"key":"8419_CR329","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4103\/1673-5374.156978","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T, Im W, Mook-Jung I, Kim M (2015) Microrna-124 slows down the progression of huntington\u2019s disease by promoting neurogenesis in the striatum. Neural Regen Res 10:786\u2013791. https:\/\/doi.org\/10.4103\/1673-5374.156978","journal-title":"Neural Regen Res"},{"key":"8419_CR330","doi-asserted-by":"publisher","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Jolissaint JFZ, Moser R et al (2013) Microrna-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific huntington\u2019s disease-related mechanisms. PLoS One 8:e54222. https:\/\/doi.org\/10.1371\/journal.pone.0054222","journal-title":"PLoS One"},{"key":"8419_CR331","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1089\/hum.2017.199","volume":"29","author":"EL Pfister","year":"2018","unstructured":"Pfister EL, DiNardo N, Mondo E et al (2018) Artificial miRNAs reduce human mutant Huntingtin throughout the striatum in a transgenic sheep model of huntington\u2019s disease. Hum Gene Ther 29:663\u2013673. https:\/\/doi.org\/10.1089\/hum.2017.199","journal-title":"Hum Gene Ther"},{"key":"8419_CR332","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gt.2017.71","volume":"24","author":"J Miniarikova","year":"2017","unstructured":"Miniarikova J, Zimmer V, Martier R et al (2017) AAV5-miHTT gene therapy demonstrates suppression of mutant Huntingtin aggregation and neuronal dysfunction in a rat model of huntington\u2019s disease. Gene Ther 24:630\u2013639. https:\/\/doi.org\/10.1038\/gt.2017.71","journal-title":"Gene Ther"},{"key":"8419_CR333","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","volume":"26","author":"MM Evers","year":"2018","unstructured":"Evers MM, Miniarikova J, Juhas S et al (2018) AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant Huntingtin lowering in a huntington\u2019s disease minipig model. Mol Ther 26:2163\u20132177. https:\/\/doi.org\/10.1016\/j.ymthe.2018.06.021","journal-title":"Mol Ther"},{"key":"8419_CR334","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.omtm.2019.03.002","volume":"13","author":"EA Spronck","year":"2019","unstructured":"Spronck EA, Brouwers CC, Vall\u00e8s A et al (2019) AAV5-miHTT gene therapy demonstrates sustained Huntingtin lowering and functional improvement in huntington disease mouse models. Mol Ther 13:334\u2013343. https:\/\/doi.org\/10.1016\/j.omtm.2019.03.002","journal-title":"Mol Ther"},{"key":"8419_CR335","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/nar\/gkz976","volume":"48","author":"NS Caron","year":"2020","unstructured":"Caron NS, Southwell AL, Brouwers CC et al (2020) Potent and sustained Huntingtin Lowering via AAV5 encoding MiRNA preserves striatal volume and cognitive function in a humanized mouse model of huntington disease. Nucleic Acids Res 48:36\u201354. https:\/\/doi.org\/10.1093\/nar\/gkz976","journal-title":"Nucleic Acids Res"},{"key":"8419_CR336","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12031-014-0290-y","volume":"53","author":"K Nolan","year":"2014","unstructured":"Nolan K, Mitchem MR, Jimenez-Mateos EM et al (2014) Increased expression of microRNA-29a in ALS mice: functional analysis of its inhibition. J Mol Neurosci 53:231\u2013241. https:\/\/doi.org\/10.1007\/s12031-014-0290-y","journal-title":"J Mol Neurosci"},{"key":"8419_CR337","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ana.24618","volume":"79","author":"L Stoica","year":"2016","unstructured":"Stoica L, Todeasa SH, Cabrera GT et al (2016) Adeno-associated virus\u2013delivered artificial MicroRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. Ann Neurol 79:687\u2013700. https:\/\/doi.org\/10.1002\/ana.24618","journal-title":"Ann Neurol"},{"key":"8419_CR338","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.omtn.2019.01.010","volume":"14","author":"R Martier","year":"2019","unstructured":"Martier R, Liefhebber JM, Miniarikova J et al (2019) Artificial microRNAs targeting C9orf72 can reduce accumulation of intra-nuclear transcripts in ALS and FTD patients. Mol Ther Nucleic Acids 14:593\u2013608. https:\/\/doi.org\/10.1016\/j.omtn.2019.01.010","journal-title":"Mol Ther Nucleic Acids"},{"key":"8419_CR339","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.2015.122","volume":"27","author":"F Borel","year":"2016","unstructured":"Borel F, Gernoux G, Cardozo B et al (2016) Therapeutic rAAVrh10 mediated SOD1 silencing in adult SOD1G93A mice and nonhuman primates. Hum Gene Ther 27:19\u201331. https:\/\/doi.org\/10.1089\/hum.2015.122","journal-title":"Hum Gene Ther"},{"key":"8419_CR340","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.omtm.2019.12.007","volume":"17","author":"AM Keeler","year":"2020","unstructured":"Keeler AM, Zieger M, Semple C et al (2020) Intralingual and intrapleural AAV gene therapy prolongs survival in a SOD1 ALS mouse model. Mol Ther 17:246\u2013257. https:\/\/doi.org\/10.1016\/j.omtm.2019.12.007","journal-title":"Mol Ther"},{"key":"8419_CR341","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/2230-973X.167646","volume":"5","author":"N Yang","year":"2015","unstructured":"Yang N (2015) An overview of viral and nonviral delivery systems for MicroRNA. Int J Pharm Investig 5:179\u2013181. https:\/\/doi.org\/10.4103\/2230-973X.167646","journal-title":"Int J Pharm Investig"},{"key":"8419_CR342","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","volume":"172","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang Z, Gemeinhart RA (2013) Progress in microRNA delivery. J Controlled Release 172:962\u2013974. https:\/\/doi.org\/10.1016\/j.jconrel.2013.09.015","journal-title":"J Controlled Release"},{"key":"8419_CR343","volume-title":"Guide to research techniques in neuroscience","author":"M Carter","year":"2015","unstructured":"Carter M, Shieh JC (2015) Guide to research techniques in neuroscience. Academic"},{"key":"8419_CR344","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2014.04.005","volume":"1584","author":"I Magen","year":"2014","unstructured":"Magen I, Hornstein E (2014) Oligonucleotide-based therapy for neurodegenerative diseases. Brain Res 1584:116\u2013128. https:\/\/doi.org\/10.1016\/j.brainres.2014.04.005","journal-title":"Brain Res"},{"key":"8419_CR345","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/0022034516633189","volume":"95","author":"N Huynh","year":"2016","unstructured":"Huynh N, VonMoss L, Smith D et al (2016) Characterization of regulatory extracellular vesicles from osteoclasts. J Dent Res 95:673\u2013679. https:\/\/doi.org\/10.1177\/0022034516633189","journal-title":"J Dent Res"},{"key":"8419_CR346","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345. https:\/\/doi.org\/10.1038\/nbt.1807","journal-title":"Nat Biotechnol"},{"key":"8419_CR347","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biomaterials.2016.07.036","volume":"105","author":"E Jang","year":"2016","unstructured":"Jang E, Kim E, Son H-Y et al (2016) Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy. Biomaterials 105:12\u201324. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.07.036","journal-title":"Biomaterials"},{"key":"8419_CR348","doi-asserted-by":"publisher","first-page":"12987","DOI":"10.18632\/aging.103385","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang H, Zhou Y, Yin Z et al (2020) Transcriptome analysis of common and diverged circulating miRNAs between arterial and venous during aging. Aging 12:12987\u201313004. https:\/\/doi.org\/10.18632\/aging.103385","journal-title":"Aging"},{"key":"8419_CR349","doi-asserted-by":"publisher","first-page":"28471","DOI":"10.18632\/oncotarget.15310","volume":"8","author":"W Xu","year":"2017","unstructured":"Xu W, Zhou Y, Xu G et al (2017) Transcriptome analysis reveals non-identical MicroRNA profiles between arterial and venous plasma. Oncotarget 8:28471\u201328480. https:\/\/doi.org\/10.18632\/oncotarget.15310","journal-title":"Oncotarget"},{"key":"8419_CR350","doi-asserted-by":"publisher","first-page":"e24145","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner MB, Kao SC, Edelman JJ et al (2011) Haemolysis during sample preparation alters MicroRNA content of plasma. PLoS One 6:e24145. https:\/\/doi.org\/10.1371\/journal.pone.0024145","journal-title":"PLoS One"},{"key":"8419_CR351","doi-asserted-by":"publisher","DOI":"10.1002\/cpph.29","volume":"79","author":"S Ramanathan","year":"2017","unstructured":"Ramanathan S, Shenoda BB, Ajit SK (2017) Overview of microRNA modulation in analgesic research. Curr Protoc Pharmacol 79:9.25.1\u20139.25.10. https:\/\/doi.org\/10.1002\/cpph.29","journal-title":"Curr Protoc Pharmacol"},{"key":"8419_CR352","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2024.020501","volume":"34","author":"M Zendjabil","year":"2024","unstructured":"Zendjabil M (2024) Preanalytical, analytical and postanalytical considerations in circulating MicroRNAs measurement. Biochem Med 34:020501. https:\/\/doi.org\/10.11613\/BM.2024.020501","journal-title":"Biochem Med"},{"key":"8419_CR353","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12687","volume":"17","author":"T Huan","year":"2018","unstructured":"Huan T, Chen G, Liu C et al (2018) Age-associated microRNA expression in human peripheral blood is associated with all\u2010cause mortality and age\u2010related traits. Aging Cell 17:e12687. https:\/\/doi.org\/10.1111\/acel.12687","journal-title":"Aging Cell"},{"key":"8419_CR354","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E (2022) Emerging concepts of MiRNA therapeutics: from cells to clinic. Trends Genet TIG 38:613\u2013626. https:\/\/doi.org\/10.1016\/j.tig.2022.02.006","journal-title":"Trends Genet TIG"},{"key":"8419_CR355","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejpb.2018.04.018","volume":"128","author":"AE Labatut","year":"2018","unstructured":"Labatut AE, Mattheolabakis G (2018) Non-viral based MiR delivery and recent developments. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV 128:82\u201390. https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.018","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV"},{"key":"8419_CR356","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha JT, Wang Y, Ma H et al (2021) Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther 6:1\u201324. https:\/\/doi.org\/10.1038\/s41392-021-00487-6","journal-title":"Signal Transduct Target Ther"},{"key":"8419_CR357","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/glia.23846","volume":"68","author":"D Brites","year":"2020","unstructured":"Brites D (2020) Regulatory function of MicroRNAs in microglia. Glia 68:1631\u20131642. https:\/\/doi.org\/10.1002\/glia.23846","journal-title":"Glia"},{"key":"8419_CR358","doi-asserted-by":"publisher","first-page":"101087","DOI":"10.1016\/j.arr.2020.101087","volume":"62","author":"E Proshkina","year":"2020","unstructured":"Proshkina E, Solovev I, Koval L, Moskalev A (2020) The critical impacts of small RNA biogenesis proteins on aging, longevity and age-related diseases. Ageing Res Rev 62:101087. https:\/\/doi.org\/10.1016\/j.arr.2020.101087","journal-title":"Ageing Res Rev"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08419-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08419-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08419-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:40:20Z","timestamp":1764895220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08419-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":358,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["8419"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08419-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest associated with this submission.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}